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Porous silicon (PSi) is an intriguing material for biomedical applications because
a great variation of properties can be created by adjusting fabrication parameters.
Physicochemical properties, including pore size, surface area, surface chemistry
and material dimensions, are dictating PSi behavior in biological environments.
Degradation  rate  and  drug  loading  capacity,  as  well  as  interactions  with  cell
membranes and blood proteins correlate with these properties. When material
dimensions are approaching the nanoscale, significant benefits, like efficient bio-
distribution and permeation through biological membranes, can be achieved.
Unfortunately, nanoscale objects are challenging to characterize because the
physical models that explain regularities in the nanoscale world are significantly
different compared with the macroscopic world. Thus, careful basic studies and
linking material properties to its performance is important when designing func-
tional materials for biomedical applications.
In this thesis, nanoparticle characterization with light scattering techniques
and nanoparticle properties in biologically and pharmacologically relevant con-
ditions are studied. During the research, we have found electrophoretic light
scattering (ELS)  and zeta  potential  to  be  a  convenient  way to  characterize  PSi
nanoparticles’ surface chemistry and colloidal stability. Multiangle light scatter-
ings (dynamic and static light scattering) proved to be useful phenomena when
structure, agglomeration, and size of mesoporous nanoparticles needed to be re-
vealed in their natural colloidal form. ELS studies did also show that isotonic
media and peptide adsorption play a pivotal role in the stability and zeta poten-
tial of PSi nanoparticles. These results highlight the importance of medium de-
pendent characterization of nanoparticles and show the versatility of light scat-
tering experiments for this purpose.
The role of medium in loading peptides into PSi nanoparticles has also
been studied, and pH was found to have a significant effect. Despite the general
assumption, the highest loading degree was achieved in pH conditions where
the total charge of the peptide was close to zero. Peptide adsorption at low load-
ing concentrations was found to be very strong, especially on hydrophobic par-
ticles, and part of the peptide payload was irreversibly adsorbed.
In in vivo studies, the loading of peptides into PSi nanoparticles sustained
the peptide release in subcutaneous delivery from 26 min to more than 20 hours.
Intravenously administered nanoparticles did not cause notable sustained re-
lease. These results are indicating that loading conditions may affect the release
of peptides from PSi nanoparticles. The possibility to tune the peptide release by
altering loading conditions makes PSi nanoparticles an interesting candidate for
the sustained subcutaneous delivery of peptide drugs.
Tiivistelmä
Huokoisen piin (PSi) ominaisuuksia pystytään säätelemään helposti valmistus-
parametrien avulla ja tästä johtuen materiaalilla on lupaavia biolääketieteellisiä
sovelluksia. Nämä fysikaaliset ja kemialliset ominaisuudet, kuten huokoskoko,
pinta-ala, pintakemia ja yhden yksikön mittasuhteet, määrittelevät materiaalin
käyttäytymistä biologisessa ympäristössä. Muutamia mainitakseni, ominaisuuk-
silla on vaikutusta PSi:n hajoamisnopeuteen ja lääkelatauskapasiteettiin, sekä
sen vuorovaikutukseen solukalvon ja veren proteiinien kanssa. Kun yhden yksi-
kön mittasuhteet lähestyvät nanomittakaavaa, voidaan biologisissa sovelluksissa
saavuttaa huomattavia etuja. Näitä ovat esimerkiksi materiaalin tehokas leviä-
minen elimistössä ja kulkeutuminen biologisten esteiden läpi. Juuri tästä pie-
nestä mittakaavasta johtuen materiaalin karakterisointi on kuitenkin haastavaa.
Nanomittakaavan lainalaisuudet eroavat merkittävästi intuitiivisestä käsitykses-
tämme materiaalin vuorovaikutuksesta ympäristön kanssa. Näin ollen perustut-
kimus, jonka tulosten perusteella materiaalin ominaisuuksia pyritään kytke-
mään materiaalin käyttäytymiseen biologisessa ympäristössä, on erittäin tärkeää.
Olen väitöskirjassani tutkinut nanopartikkelien karakterisointia valon-
sirontatekniikoiden avulla, sekä nanopartikkelien ominaisuuksia farmaseutti-
sesti ja biologisesti relevanteissa väliaineissa. Olemme tutkimuksessa huoman-
neet elektroforeettisen valonsironnan (ELS) ja tästä mittauksesta saatavan suu-
reen, zeta potentiaalin, hyödyllisyyden PSi nanopartikkelien pintakemian ja kol-
loidisen stabiiliuden karakterisoinnissa. Monikulmasirontamenetelmät (dynaa-
minen ja staattinen valonsironta) osoittautuivat hyödyllisiksi mitattaessa meso-
huokoisten nanopartikkelien rakennetta, kokoa ja agglomeroitumista niiden
luonnollisessa kolloidisessa olomuodossa.
Valonsirontamittaukset osoittivat myös, että isotoninen väliaine ja pepti-
diadsorptio vaikuttavat oleellisesti nanopartikkelien stabiilisuuteen ja zeta po-
tentiaaliin. Tämän innoittamana tutkimme väliaineen roolia myös peptidien la-
tautumisessa ja tuloksena huomasimme pH:n suuren vaikutuksen latausastee-
seen. Yleisesti oletettu käsitys on, että peptidit latautuvat parhaiten vastakkais-
merkkisesti varautuneisiin nanopartikkeleihin. Varauksien erimerkkisyyden
huomattiin kuitenkin olevan vain vähäisessä roolissa, sillä paras latausaste saa-
vutettiin peptidien ollessa kokonaisvaraukseltaan mahdollisimman lähellä neut-
raalia. Adsorptio matalissa peptidikonsentraatioissa oli erittäin voimakasta eri-
tyisesti hydrofobisten partikkelien tapauksessa. Lisäksi huomattiin, että osa la-
tautuneista peptideistä oli adsorboitunut irreversiibelisti.
In vivo -kokeissa peptidien ihonalainen annostelu PSi nanopartikkeleihin
ladattuna hidasti peptidien vapautumista 26 minuutista yli 20 tuntiin. Suonen-
sisäisesti annosteltuna nanopartikkelit eivät merkittävästi pidentäneet vapautu-
misaikaa. Tuloksista voidaan päätellä myös, että latausolosuhteet saattavat vai-
kuttaa peptidien vapautumiseen nanopartikkeleista. Mahdollisuus vaikuttaa
peptidien vapautumiseen latausolosuhteita muuttamalla saattaa tulevaisuu-
dessa auttaa hallitsemaan peptidien ihonalaista annostelua.
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1.1 Establishment of nanotechnology
The story of nanoscience and nanotechnology differs from typical scientific nar-
ratives because it is a mix of science, popular science, and politics. Since all these
approaches are important for the existence of this thesis and I feel that leaving
some of these out would not be the whole truth, I will here describe my interpre-
tation of the history of nanotechnology based on these three institutions.
The most significant political act in history of nanotechnology was the es-
tablishment of U.S. National Nanotechnology Initiative (NNI), an achievement
of President Clinton in 2000, which directed significant amount of research fund-
ing to promote nanotechnology in the United States. The European Union fol-
lowed right behind and in 2003, the 6th Framework Programme for Research and
Technological Development was started, with nanotechnologies and nanosci-
ences as one of the thematic areas1. Promises of nanotechnology, which we will
get to know in more detail in next chapters, tempted Finnish scientists, also. The
fastest response to this increasing interest came from University of Jyväskylä,
where in 2001, nanoscientists, together with the university governance, decided
to build a new building for the purpose of nano research [1].  This project was
special on a global scale, as until then, a typical nanoscience center was only a
virtual construction. This joint project, and the commitment of scientists and gov-
ernance, established the role of the University of Jyväskylä in nanoscience. When
the new National Graduate School in Nanoscience (NGS-NANO) started in 2006,
the responsibility of coordination was given to the University of Jyväskylä.
The NNI defines the nanotechnology as follows2:
1 The Sixth Framework Programme in brief, online citation 8.12.2016, https://ec.europa.eu/re-
search/fp6/pdf/fp6-in-brief_en.pdf
2 What is Nanotechnology?, online citation 8.12.2016, http://www.nano.gov/nanotech-
101/what/definition
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Nanotechnology is science, engineering, and technology conducted at the
nanoscale, which is about 1 to 100 nanometers. Nanoscience and nanotechnology
are the study and application of extremely small things and can be used across all
the other science fields, such as chemistry, biology, physics, materials science, and
engineering.
This is quite a common definition, and it mentions two of the most guiding fea-
tures of nanoscience and nanotechnology: the size scale and interdisciplinary na-
ture of the field. Although both of them are, every now and then, argued.
When it comes to science and popular science, the official (as defined by
NNI) privilege to be called the “father” of nanotechnology is commonly given to
U.S. physicist Richard Feynman because of his famous talk,  “There's Plenty of
Room at the Bottom.” The adaptation of the talk can be found for example, in
reference [2]. In the talk, he envisions his idea of how much room there still is to
decrease the size of machines before they are limited by the laws of physics. Feyn-
man was a world known lecturer and physics Nobel Prize Winner, thus the talk
was brilliant with no doubt, and might have even included some new perspec-
tives. However, it is easy to agree with Toumey, who states in his column in Na-
ture Nanotechnology special Feynman edition, that the scientific impact of the
talk for the field of nanoscience was not that large [3]. One of the arguments that
supports this opinion is that it took about 30 years before Feynman’s ideas were
discovered again and harnessed for use in the nanoscience narrative. Meanwhile,
almost no attention to these predictions was given. The talk was published sev-
eral  times,  but  despite  this,  it  gathered  almost  no  citations  during  the  first  20
years. This is especially significant since in 1950s, Feynman was already a recog-
nized scientist, as indicated by the 160 citations3 that one of his most successful
articles [4] gained during first 20 years, even though the Second World War de-
creased the scientific efforts at the same time.
One  of  the  earliest  citations  to  Feynman’s  talk  is  in  the  article  of  Eric
Drexler in 1981 [5]. He refines Feynman’s idea about tiny machines and explains
how it  should be possible to create them with molecular engineering. In 1986,
Drexler wrote a whole book, Engines of Creation [6], around this interesting idea,
and it started gaining public attention. In Drexler’s vision, in the near future, it
should be possible to build nanomachines that could fabricate things in the mac-
roscale and, in addition, replicate themselves. As one can imagine, these ideas,
especially the idea of replication, had a lot of influence on science fiction, and the
threats of nanoscience came into public discussion, before the actual field even
existed.
3 According to Google Scholar 28.11.2016
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At the same time, with or without contribution from the nano hype, the
advances towards the nanoscale were also made on the scientific side, especially
on microscopy. Atomic-force microscopes were discovered in the 1980s [7]; this
also enabled the first actual atom-by-atom structures fabricated in 1990 [8]. Also
electron microscopes and especially sample fabrication procedures advanced
during 1980s and 1990s from which one real life example considers myosin which
was imaged on action, “walking” along F-actin [9].
One of the influential popularizer and educator in the field of the nanosci-
ence is Richard Jones, whose book “Soft machines” was published in 2004 [10].
Jones placed molecular engineering in one of the three subfields of nanotechnol-
ogy called radical nanotechnology.  He also pointed out that it  is  important to
understand the nanoscale physics, which could be very different from the phys-
ics  in  the  macroscopic  world.  This  was  thought  to  be  a  limitation of  Drexler’s
approach. Two other subfields were incremental nanotechnology and evolution-
ary nanotechnology. Incremental nanotechnology aims to improve materials
through nanoscale modifications. One very recent advancement of this kind is
UltraRope, developed by Kone 4 . The strong carbon (nano)fiber core enables
longer elevators to higher buildings due to the lighter weight of the rope. Evolu-
tionary nanotechnology aims towards developing more active materials such as
nanoscale transistors and sensors. This kind of development on transistors has
been evident for a long time, being accelerated by the strong commercial need
for smaller microelectronics. When in the 1980s the size of the smallest feature on
microprocessor could be decreased to under 1 µm [10]; it is now 14 nm in com-
mercial processors5.
In  the  scientific  background of  this  work,  there  are  three  different  disci-
plines which have something to do with the “nano”. The first of them is perhaps
most influenced by the hype of nanotechnology; since after the establishment of
NNI, the number of nanopharmaceuticals have been rapidly growing [11,12].
This research is considered to originate from the studies of controlled drug de-
livery systems (DDS) which have been studied since the 1950s [13]. In the 1960s,
polymer based DDSs were discovered, and in the 1970s, the research of nanopar-
ticles, or colloidal particles (as they were called in those days), began to gain at-
tention in the field. This takes us to the second tradition called colloid science.
Colloid scientists have a long tradition of characterizing nanoparticles in
liquid medium, which is important when biological or pharmaceutical applica-
tions are considered. The political emergence of nanoscience has caused an espe-
4 KONE UltraRope, online citation 8.12.2016, http://download.kone.com/ultrarope/index.htm
5 Your Source for Intel® Product Specifications, online citation 8.12.2016, http://ark.intel.com/
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cially strong identity crisis in the field of colloidal sciences [14]. Colloidal disper-
sion can be defined as a heterogeneous mixture of two or more substances, where
at least one component occurs in non-continuous, dispersed, form and the other
in form of continuous medium [15].  The size of dispersed objects can vary be-
tween 1 nm and 1 µm, by definition. It does not matter what is the actual state of
the matter and almost all the three basic states occur. The only exception is gas
as both the continuous and non-continuous components in one system. Mixtures
of two immiscible liquids (like oil and water) are called emulsions, solid or liquid
particles dispersed in gas (like smoke or fog) are called aerosol, and gas in liquid
is called foam. Mixtures of solid particles and liquid medium are often called
suspensions. Nanoparticles are, in most cases, well dispersed and stable in liquid
medium, in which case, the terms colloidal dispersion or colloidal suspension
can be used. For simplicity, the word suspension is used to describe this kind of
system.
The third  tradition is  the  development  of  porous  materials.  Again,  even
before nanoscience, researchers studied these materials, classifying by pore di-
ameter into three different groups. The pores with diameter less than 2 nm are
called micropores, 2-50 nm pores are mesopores and pores larger than 50 nm are
called macropores [16]. With the same logic, a material can be defined micro-,
meso- or macroporous. As we will see in the next chapter, the discovery of the
material that I have mainly studied, porous silicon (PSi), dates back to the 1970s
when the porosity was measured for the first time. Nevertheless, on those days,
there was more than 200 years history of research on microporous materials
called zeolites [17].
Therefore, when we are manipulating and applying different kind of pores
on PSi, we are doing nanoscience by the definition of NNI. On the other hand,
we are willing to utilize the interesting properties of this nanomaterial in partic-
ular forms in the DDS field. Because of this, we adapt the definition of nanopar-
ticle from the field of colloidal science and nanopharmacy and work in the area
well  below  1  µm.  This  we  do  by  keeping  in  mind  as  Richard  Jones  has  writ-
ten [18]:
Perhaps Feynman can be credited, above all, for making nanotechnology a field
driven  by  imagination  and  visions  of  the  future.  Something  else  that  we  might
usefully take from his lecture is the importance of a spirit of play and the drive to
achieve new technical feats just because you can. Ultimately, what’s important is
not what you can imagine, but what you can make.
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1.2 Discovery of porous silicon
The discovery of porous silicon (PSi) dates back to 1956 with early electrochemi-
cal studies on silicon. While studying the electrolytic shaping of silicon, Arthur
Uhlir and his wife Ingeborg Uhlir discovered the formation of a dark matte layer
on a top of the silicon wafer  [19].  This layer,  which they thought to be silicon
suboxide, was unwanted, and they did not notice its porosity.  Two years later
Turner, in his article concerning electrochemical anodization of silicon [20],
stated as follows:
At a critical current density, the thick film suddenly starts coming off and floats to
the surface.
He had found out that the dark layer, which he actually suspected to be porous,
was possible to detach by increasing the current density above the critical point,
to the so-called electropolishing region. During the next ten years, different ways
to form the same kind of films on top of the silicon substrate were discovered.
These studies concerned mainly anodic oxidation, electropolishing, and chemical
etching [21]. Puzzled by the colored stain films on top of the silicon, which fol-
lowed by etching it in aqueous solution of hydrofluoric acid (HF) and nitric acid
(HNO3), Archer made the first thorough study on the technique called stain etch-
ing in 1960 [22].  The first light assisted (photoelectrochemical) etchings were
made by Dalisa et al. in 1970 [23].
Finally in 1971, Watanabe et al. verified the porous nature of the film [24].
This  discovery  gave  the  first  thrust  to  an  increasing interest  on  PSi.  The  main
applications for PSi in these early studies were limited mainly to the develop-
ment of an insulating material on microelectronic circuits [25,26]. The next wave
came along the discovery of Leigh Canham in 1990, when he noticed the visible
photoluminescence of PSi at room temperature [27]. Right after this, the electro-
luminescence of PSi was also discovered [28]. The growing interest to new mate-
rials for light emitting diodes (LED) boosted the PSi research [29] and number of
different fabrication techniques grew significantly. Despite the promising use of
PSi in integrated circuits, the properties of the material were not good enough,
and the PSi LED remained as a promise [30].
In 1995, the enormous impact of Leigh Canham to the research of PSi was
sealed when he  found the  first  hints  of  the  biocompatible  nature  of  the  mate-
rial [31]. He found that hydroxyapatite, the major constituent of bone, was grow-
ing to the surface of PSi in biologically relevant phosphate-buffered saline (PBS).
In addition, PSi showed signs of degradation in physiological conditions. Soon
after this, the ability of cells to adhere PSi surface was recognized [32]. These
16 Background
findings initiated the research of PSi into a completely new area of medical ap-
plications, which was the final step giving PSi broad interest.
2 Fabrication of mesoporous nanoparticles
Until  today,  more  than  30  different  techniques  to  fabricate  PSi  with  different
structures and properties are known [33]. Despite the variety of fabrication tech-
niques, the most used is still the electrochemical etching or anodization. The rea-
son for this is the possibility to control the properties of PSi with the etching pa-
rameters.
2.1 Electrochemical anodization
During electrochemical etching, pores are formed due to the highly localized
electrochemical dissolution of the crystalline silicon. Parameters affecting the for-
mation rate and pore morphology are electrolyte composition, dopant type and
concentration, crystal orientation, current density, temperature, and illumina-
tion [34]. In the simplest fabrication setup, only HF-compatible plastic vial, elec-
trolyte,  platinum  counter  electrode,  anode  connector,  and  power  supply  are
needed. However, the homogeneity of the formed PSi layer depends on the qual-
ity of the contacts and the homogeneity of the formed electric field. Hence, in
most cases the time or money is invested for design and manufacturing of the
dedicated etching cell (Figure 1).
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Figure 1.   (a) A single tank PSi etching cell for 100 mm Si wafers, fabricated from Teflon
with a stainless steel frame. (b) Lower part of the etching cell, showing the metallic back
contact for the Si wafer. The set-up is published in reference [35]. The figure is constructed
from original pictures with permission from Ermei Mäkilä.
The question, why the silicon dissolves in such a local fashion and the pore
walls not, has intrigued scientists since the discovery of PSi. The basic idea of an
electrochemical dissolution of silicon in HF-solution is explained in Figure 2. Sil-
icon is stable in acidic aqueous solutions if they do not contain fluoride because
a native oxide passivates the silicon surface. If the solution contains HF, slow
isotropic dissolution occurs and can be accelerated by adding the oxidizing agent.
On the anodic etching of PSi, the wafer is attached on the anode, covered with
HF electrolyte and the counter electrode is placed in the electrolyte on the top of
the wafer. The electrolyte contains	HF, (HF) , and HF  species and in p-type sili-
con  the  applied  voltage  causes  the  holes  to  drift  towards  the  surface.  As  ex-
plained in the first panel in Figure 2, the hole enables the nucleophilic attack of
HF  to the Si atom. In the next phase, the nucleophilic attack takes place without
the hole since the ionic balance of the Si—H bond changes as a consequence of
highly electronegative fluoride on the other side. In this phase, the electron injec-
tion to  silicon is  thought  to  happen and hydrogen escapes  in  a  gaseous  form.
Now, the even more pronounced ionic nature of silicon with two fluorides at-
tached enables the nucleophilic attack of HF  to silicone back-bonds and the sil-
icon atom detaches from the surface in a form of silicon tetrafluoride. It immedi-
ately reacts with HF and forms a stable and liquid hexafluoride molecule SiF .
It should be noted that dissolution of silicon starts from the hydrogen terminated
surface and results to the same situation.
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Another important phenomenon is that the first phase, where the hole is
enabling  the  nucleophilic  attack,  is  rate  limiting.  In  the  case  of  p-type  silicon,
holes are on material typically as a consequence of boron doping. In n-type sili-
con, charge carriers are electrons and the holes need to be created with a power-
ful illumination. This is the first factor affecting pore formation. In addition, there
are several different theories, which all have their relevance in certain cases, but
none conclusive, all explaining theory for formation mechanism has been formu-
lated and agreed.
One of the explaining models is the crystal face selectivity. Pores tend to
grow in <100> directions which is explained by the higher dissolution tendency
of  the  (100)  surface  compared  for  example,  with  the  (111)  surface  on  pore
walls [36]. Another explanation for the aligned pores is the charge carriers’ route
of the lowest resistance. Because the electrolyte is typically more conductive than
the silicon substrate, the easiest way to the electrode is from the bottom tip of the
pore. In addition, high curvature of the pore tip yields to the higher electric field
and subsequent increase of the hole concentration and dissolution rate. On the
other hand, the decreased hole concentration plays a role in decreased dissolu-
tion  of  pore  walls.  This  is  caused  by  the  so-called  space-charge  region  (SCR),
which is formed near the silicon/electrolyte interface where the energy bands
bend as a result of charge equilibration between the semiconductor and the elec-
trolyte. This region is spatially so large that it can prevent the charge transport to
the pore walls.
For drug delivery purposes, mesoporous structures are typically the most
wanted outcome of anodization. For the etching process, the first thing that needs
to be selected is the wafer’s doping type and concentration. With highly doped
n+, p+ or p++, it is possible to fabricate mesopores [21,36]. In the case of p-type
silicon, the diameter of formed pores decreases when the dopant concentration
decreases (Figure 3). For n-type silicon, the effect is typically the opposite.
Figure 2. Anodic divalent dissolution of silicon in HF [21]. © 2002 Wiley-VCH Verlag
GmbH. Reproduced with permission from Wiley Materials.
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In the following step, the electrolyte needs to be decided. Fluoride is natu-
rally an important part of the electrolyte, but luckily, the etching is not too sensi-
tive to this concentration as long as it is sufficiently high. During the etching, the
fluoride concentration is harder to keep constant close to the surfaces and espe-
cially in pore tips. For this purpose, some etch pauses may need to apply. Local
deficit of fluoride yields to the formation of insulating surface oxide which leads
to pore widening and electropolishing. In addition, ethanol is used as a surfac-
tant in the electrolyte in order to promote the evolving hydrogen bubbles’ de-
tachment from the surface.
The parameter which is the easiest to adjust, even during the etching, is the
current  density  [37].  The  current  density  does  not  significantly  affect  the  pore
size in the case of p-type silicon, but density of pores increases while the current
density is increased (Figure 3).
Figure 3. Cross-sectional SEM image of PSi layers etched in ethanoic HF with different
current densities and p-type dopant concentrations. Reprinted from reference [38] with
permission from Elsevier (© 2000).
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2.2 Surface passivation
The etching process  leaves  the  surface  of  PSi  hydrogen terminated (Figure  2),
which is prone to oxidation. The great benefit of the top-down nanomaterial such
as PSi, which can be easily handled in the dry state, is the possibility to use ther-
mal gas phase treatments for comprehensive stabilization of the surface.
2.2.1 Thermal oxidation
Oxidation is the most common way to stabilize the silicon surface owing to its
simplicity and because of a versatile variety of chemical entities that would be
possible to attach to the surface via siloxane bonds [36,39]. Oxidation can and
will  take  place  in  ambient  air  as  so  called native  oxidation and its  rate  highly
depends on humidity and temperature [34]. Native oxidation is a slow process
and does not provide decent chemical stability for most applications. Oxides that
are  more  durable  can be  made with  chemical  treatments  by  boosting aqueous
oxidation with an oxidizing agent like HNO3 or  in  gas  treatments  where  in-
creased temperature is used to enable reactions that require more energy and
speed up diffusion of the oxide into the crystalline silicon matrix.  The latter is
called thermal oxidation (TO), and it is commonly used in microelectronics in-
dustry for the production of high quality oxides on silicon wafers [36]. In thermal
oxidation, the used atmosphere, temperature, and treatment time play a major
role. The so called back-bone oxidation takes place in ambient air at temperatures
above 250 °C [40]. The siloxane bridges are formed between silicon atoms at the
surface  and at  the  second atom layer  (Si—O—Si—H) during this  process  [41].
Due to the slightly stronger nature of Si—H bond to resist oxidation, some sur-
face hydrides still remain on the surface after the back-bond oxidation. When the
temperature is raised to 700 °C, the hydrides are completely desorbed [39]. The
drawback is that high treatment temperatures could cause reformation of the
pores. The oxide structure on top of PSi resembles amorphous silica [42] which
suffers from poor stability in alkaline media [43]. There are a lot of benefits to
oxide passivated surfaces, but for some applications, like in sensors [44] and drug
delivery  [45],  its  stability  against  the  dissolution  may  not  be  sufficient,  and  a
longer degradation profile is needed.
2.2.2 Thermal carbonizations
When a more durable surface is needed, surface treatment with carbon is a com-
monly used method. This can also be done in a solution or in a dry state. The first
method for the carbon stabilization was the so called hydrosilylation, which was
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actively studied at the turn of the century. Lewis acid catalysis [46], white or UV-
light [47], or increased temperature [48] was used in order to initialize a reaction
between unsaturated organic molecules and silanes (Figure 4).
Figure 4. Hydrosilylation reaction of PSi surface hydride with double bond terminated
alkene [36]. Reproduced with permission from Wiley-VCH Verlag & Co. KGaA (© 2012).
At the same time, thermal gas phase treatments were also developed to
introduce carbon into the PSi structure. This so called thermal carbonization is
carried out by pre-exposing the fresh etched PSi film to a mixture of inert carrier
and carbon containing gas, such as a mixture of acetylene and nitrogen [49,50].
During the pretreatment, acetylene molecules are adsorbed to the PSi surface.
Heating yields to the breaking of the double bond and disintegration of carbon
atoms, but the high activation energy of desorption keeps molecules attached to
the surface [51]. The treatment temperature has a significant impact on the hy-
groscopic properties of the formed surface [52], which is attributed to changes in
surface chemistry [53,54]. When the treatment temperature is kept below 700 °C,
the  thermal  energy cannot  break all  of  the  C—H bonds,  and the  surface  stays
covered with hydrophobic hydrocarbons. When the temperature is raised above
700 °C, all the hydrogen desorbs from the surface and carbon diffuses deeper into
the structure [55]. This leaves a very thin, non-stoichiometric silicon carbide
structure on the surface, which will become terminated with a thin oxide layer
after the treatment is done and the films are taken back into ambient air [56]. The
thin oxide layer makes the surface hydrophilic. In order to distinguish these sig-
nificantly different surface chemistries, thermal carbonization (TC) refers to acet-
ylene treatment at higher temperature, and thermal hydrocarbonization (THC)
refers to acetylene treatment at lower temperature (Figure 5).
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Figure 5. C2H2-based thermal carbonization treatments for fresh PSi. (i) THC process is
done by exposing the PSi to C2H2 on a moderate temperature (450−600 °C). (ii) TC treat-
ment  is  done  in  high  temperature  (700−900  °C)  N2 treatment immediately after the
THCPSi treatment. (iii) Alternatively TCPSi treatment can be made directly to fresh PSi.
Drawing was made as proposed in [35] and [56].
2.2.3 Functionalization of TC and THC surfaces
The benefit of thermal stabilization of PSi in the gas phase is the high sur-
face coverage of the stabilizing layer. This layer, for the most part, determines the
material stability against degradation and uncontrolled oxidation. Nevertheless,
these surfaces are not necessarily optimal for biological applications and further
modifications may be needed. Varieties of organosilanes can be attached to the
silicon oxide surface via rather stable siloxane (—Si—O—Si—R) linkage [57,58].
One frequently used organosilane is APTES (3-aminopropyltriethoxysilane),
which creates an amine termination and positive charge on the surface [59], and
it is widely used to attach biomolecules to silica surfaces. As we have shown in
Paper II,  silane coupling chemistry can also be used with TC surfaces because
carbon penetrates deeper into the structure and silicon oxide covers the surface.
This can be changed to a hydroxyl termination simply by dipping the sample in
a HF containing solution. Thermal carbonization makes structure of PSi durable
against dissolution and can also increase the stability of amine treatment when
compared to TOPSi (Paper II).
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The situation is different when the functionalization needs to be made for
a hydrophobic THCPSi surface. Now, the hydrocarbon groups terminate the sur-
face and silane chemistry is not conveniently applied. Nevertheless, THCPSi sur-
face provides superior stability against aqueous degradation, which is a desired
property in some applications. In recent studies, functionalization of THCPSi
surface has been managed to produce with the radical coupling of a dicarboxylic
acid (sebacic acid) using a benzoyl peroxide initiator [60] and hydrosilylation re-
sembling thermal reaction of unsaturated carboxylic acid (undecylenic acid) [61].
The strong C—C bond between the carbon on PSi surface and hydrocarbon chain
shows excellent stability compared to many other surface chemistries [62] and
also  provides  a  route  for  further  functionalization  via  carboxylic  acid  groups.
Undecylenic acid functionalized THCPSi particles are herein abbreviated to Un-
THCPSi.
2.3 Fracturing methods
Unlike most nanomaterials, PSi nanoparticles are fabricated with the top-down
method, and different kinds of techniques for the disintegration of the nanopar-
ticles from the PSi film have been developed. PSi can be a very fragile material at
the nanoscale, and this fact was utilized when first PSi based nanoparticles were
made in the beginning of the 1990s [63,64]. These nanoparticles appeared in ul-
trasonic treatments of highly porous silicon matrixes. According to Bley et al., the
size of these particles was typically below 50 nm, but the wide size range was
explained by agglomeration of smaller Si crystallites in the size range of 2-11 nm.
In this case, the concept of porous nanoparticles should not be used as it is evi-
dent that the original porous structure was destroyed during the treatment.
During the first five years of new millennium, the first reports of PSi par-
ticles being used for drug delivery purposes [65–67] were published. In these
studies, microparticles were fabricated either by photolithographic method [65]
or by milling with planetary ball mill [67]. For the photolithographic method, the
silicon nitride layer is first deposited to the Si surface. This layer is covered with
photoresist that is photolithographically patterned, and the formed template is
plasma etched. The porous structure is etched with electrochemical anodization
on the spots where silicon is exposed to the electrolyte, and a subsequent elec-
tropolishing pulse is used in order to detach the particles from the wafer. This
method facilitates the etching of microparticles with rigorously controlled shape
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and size [68]. Planetary ball milling, on the other hand, can be used for the pro-
duction of much larger amounts of microparticles in one batch, but the control
over shape and size is more complicated.
A few years later, the first paper concerning in vivo studies of the PSi na-
noparticles was published. Particles were made with the ultrasonic treatment,
but  now with  the  production of  PSi  nanoparticles  with  actually  porous  struc-
tures [69]. A year later, ball milling was also used for the same purpose [70]. On
the latter study, the possibility to control the size of PSi nanoparticles in one di-
mension by multilayer  etching [71]  was  utilized for  the  first  time.  Despite  the
significant amount of studies on these top-down fabricated PSi nanoparticles, the
fracturing methods are not well understood. In 2014, Qin et al. were able to
achieve the size control and increased yield with multilayer etching of PSi and
ultrasonic fracturing [72]. Nissinen et al. recently made a similar study with mul-
tilayer etching and ball milling. They noted that multilayers might increase the
yield of the nanoparticle production, but the size control is hard to achieve [73].
One of the problems with fracturing methods is that the simultaneous creation
of Si nanocrystals (<< 100 nm) is impossible to avoid [74], and these particles
might  cause  problems  in  characterization  and  applications  if  they  are  not
properly washed away on the separation process. Both of these fabrication meth-
ods result in a very wide particle size distribution, where particle size vary from
nanoscale to micrometer regime. Thus the additional separation step, in order to
extract the wanted fraction of nanoparticles from the rest of the mixture, needs
to be done by centrifuging or filtering.
Figure 6. (Left) Microscope image (multiple images combined, no in scale) is from unfrac-
tioned PSi particles with multilayer structure clearly seen. (Right) Centrifuged and fil-
tered PSi nanoparticles imaged with TEM.
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Lithographic methods have also evolved towards the nanoscale, but the
size of these particles is still around 1 µm [75]. The benefit of this method, also in
nanoscale,  is very robust control over the geometry of the particles which, can
vary from hemispherical [68] to discoidal [76]. Recently, the colloidal litho-
graphic method [77] and the imprinting method [78] have been developed,
which might offer more cost effective PSi patterning methods in the nanoscale.
2.4 Mesoporous silica nanoparticles
The fact that there is an another silicon based mesoporous material is easily caus-
ing confusions. This material is mesoporous silica — not silicon. The discovery
of mesoporous silica also occurred during the last half of the 20th century. In 1968,
when chemists  were  already familiar  with  the  sol-gel  method,  where  through
hydrolysis and polymerization, tetraethyl orthosilicate (TEOS) was turned into
silica (SiO2) [79], Stöber et al. [80] decided to modify the process and use an alka-
line solution to catalyze the reaction. They managed to create extremely mono-
disperse silica colloids with controllable particle size from 0.05 µm to 2 µm. The
final size of formed silica particles depended on the concentration of components
and the type of the used silicon alkoxide precursor. After this, temperature was
also shown to play a role in the process [81].
There is evidence that mesoporous silica was actually fabricated right after
Stöber’s publication in 1971, but the porosity was not noticed [82]. Thus, the ac-
tual discovery of the material dates to the beginning of 1990s [83] to the labora-
tory of Mobil Research and Development Corporation in New Jersey, USA. They
named the material MCM-41 according to the company’s naming tradition. The
porosity was generated with self-assembling nanoscale templates, which were
covered by polymerizing silicates. Templating was done with the surface-active
molecules (surfactants), which in aqueous solution have a tendency to cluster
together to form micelles, as they are called.
Surfactants have a hydrophobic end which tries to avoid contact with wa-
ter and a hydrophilic end which favors the water contact. When the concentra-
tion of these molecules in water is high enough, they are entropically driven to
form clusters where the hydrophobic parts are shielded from the aqueous envi-
ronment. Depending on the concentration and the dimensions of the surfactant,
they may form spheres,  rods, or layers.  The dimensions of the surfactant’s hy-
drophilic and hydrophobic end can be used for the determination of the so called
packing parameter / , where  and  are the volume and effective length of
the hydrocarbon chain, and  is the optimal surface area per molecule [84]. The
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smaller the hydrophobic part on the molecule is, the more probable the formation
of a spherical micelle. When the size of this end is increased, the cylinder becomes
the preferred shape, which follows the lamellar structure (Figure 7).
Figure 7. The self-assembled structures with different surfactant packing parameter and
hydrophilic-lipophilic balance (HLB) number. Reprinted from [85] with permission from
Elsevier (© 1994).
There are several synthesis routes for the formation of silica particles, but
for the fabrication of mesoporous nanoparticles, alkaline synthesis with a cati-
onic surfactant is preferred [86]. In the alkaline environment, electrostatic inter-
action between negatively charged silica species and positively charged template
surfactants yields to the formation of silica walls around the self-assembled (liq-
uid crystal) structures. Particle formation starts with fast nucleation silicates and
continues with a slower growing period. Two of the most important parameters
for a monodisperse suspension and size control are low concentration of silicate
precursors and high pH. The alkaline environment is preferred so that the attrac-
tive interaction between the formed particles can be avoided, as it typically yields
to the coalescence of particles into increasingly larger structures (so called Ost-
wald ripening). Different chemical additives, called particle growth quenchers,
can also be used to control particle size.
Basic synthesis of silica yields the negatively charged surface caused by the
silanol groups [86]. By co-condensation of alcoxysilanes together with orga-
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nosilanes (with amine or carboxylic acid parts), the variation of surface function-
alities can be achieved. Alternatively, silica particles can be functionalized post-
synthesis via siloxane bonds as explained in Chapter 2.2.3.
3 Biomedical applications of porous silicon
The diverse collection of techniques available for a fabrication of PSi has gener-
ated diverse forms of materials [87]. Porous silicon can be used as a nanoparticle
suspension, a microparticle powder, a membrane, or a layer. As silicon is widely
used as a material in microelectronics, PSi can be easily integrated to electrical,
optical or mechanical devices. In this section, I will limit the discussion to particle
based biomedical  applications.  This  casts  off  almost  completely  the  important
application area in biomedical fields, biosensors, but does not mean that the field
is insignificant or passive. Significant amount of PSi research takes place aiming
towards biosensor applications [88,89].
For  PSi  particles,  the  drug  delivery  devices  are  the  most  important  and
widely studied applications [34,90]. These can be broadly divided into three cat-
egories depending on the benefit that porous matrix can offer: the possibility to
control (typically to sustain) the drug release, to provide a stabilizing matrix for
amorphous drug form, and to act as a vehicle for drug delivery, allowing longer
drug circulation time or accumulation towards a certain target.
3.1 Sustained and protected delivery of peptides
Peptides  are  small  chains  of  amino  acids,  which  differ  from  proteins  only  by
chain length. Maximum chain length for a peptide is from 50 to 100 amino acids.
It is a small molecule compared to proteins, yet typically much bigger than con-
ventional small molecular drugs. Physicochemical properties of peptides can
vary a lot, but there are still some common pros and cons compared to conven-
tional drugs.
Typical disadvantages of peptide drugs are the poor metabolic stability,
rapid clearance from the blood circulation, and poor permeability through bio-
logical membranes [91]. Despite these limitations, a number of peptide drugs are
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steadily rising [92,93] because of their potency, specificity, and broad range of
targets. In addition, the rise of biotechnological routes for the fabrication, such as
cloning and fermentation, have increased the interest on peptides [94].
The sensitivity of typical peptide drugs and the harsh environment in the
gastro-intestinal (gi) tract necessitates their parenteral administration. Subcuta-
neous (sc) and intravenous (iv) delivery are the most common methods, but the
rapid clearance from the blood forces the use of frequent injections. This means
that sustained release, with PSi particles for example, could be a relief for patients.
The benefit of PSi particles, compared to many other particulate peptide delivery
systems, is that the peptide loading can be made after the fabrication of particles,
at room temperature, and in mild solvents. This is not the case with most poly-
meric and liposomal particles, where the drug needs to be incorporated into the
delivery system during the particle synthesis.
In studies of peptide delivery with PSi, the sc administration is the most
used approach, and evidence of sustained release has been found. The first in
vivo study was done by Kovalainen (née Kilpeläinen) et al. with THCPSi micro-
particles. Ghrelin antagonist [95] and Melanotan II [96] were used as model pep-
tides. In both studies, they observed a prolonged action of model peptides, at-
tributed to sustained release. In addition, no toxic effects were observed and
THCPSi microparticles were considered a good candidate as a sustained delivery
vehicle. In a subsequent study, three different surface chemistries were tested
and peptide YY (3-36), later PYY, was used as a model drug [61]. In this study,
the sustained release was observed with all surface chemistries, and in addition,
they observed an improved absolute  bioavailability,  up to  98  % in  the  case  of
TOPSi microparticles. This is 2.5-fold increase compared to the 38 % bioavaila-
bility of sc injected PYY solution. Significant differences between surface chem-
istries were also observed since THCPSi and UnTHCPSi microparticles could not
overcome the bioavailability of the pure PYY solution. On the other hand, these
hydrophobic particles showed slower release compared to TOPSi. Similar stud-
ies were made also with PYY and PSi nanoparticles (Paper III), but they are dis-
cussed in more detail in the results.
Oral delivery is naturally simple and has the highest degree of compliance,
and numerous methods have been proposed to overcome the problems in gi
tract [97]. Chemical modification of peptides is one of the most popular methods,
but, since maintaining the therapeutical efficacy is obviously important, a trial
and error approach might be time-consuming [94]. Another, quite general, strat-
egy is to add additives such as absorption enhancers, enzyme inhibitors, or par-
ticle  carriers  to  the  formulation.  The  problem in  this  approach is  the  potential
toxicity of the additives. Potential toxicity might also be a challenge for the PSi
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based delivery, but the idea that the mesoporous matrix could provide protection
and control over the release has tempted researchers, although the task is chal-
lenging. The first hints of enhanced permeation of insulin through typical intes-
tinal cell line model, Caco-2, was obtained by Foraker et al. in 2013 [65]. The next
studies mainly considered stability of proteins on loading and release [98,99],
and the idea of chitosan functionalization as a mucoadhesive coating of PSi [100].
Recently, an especially large contribution to this topic have been made by
Francisca Araújo and Neha Shrestha from Helder Santos’s research group [101–
107]. They have linked chitosan mainly to UnTHCPSi nanoparticles and, in stud-
ies with epithelial cell models, noticed the increased mucoadhesion, increased
cell uptake, and enhanced permeation of peptide drugs when compared to pep-
tide solution. Peptides, which were mainly used, were insulin and glucagon-like
peptide-1 (7-37), later GLP-1, although some preliminary experiments were
made with PYY also. In order to create a pH sensitive polymer coating around
the  particles  to  avoid the  release  and degradation of  peptides  in  the  stomach,
they have used the microfluidic synthesis or airflow reactor (AFR). They have
also successfully added the DPP4 protease inhibitor to the enteric coating to en-
sure the protection against the enzymic degradation in a stomach. After promis-
ing in vitro results, they showed in vivo that this coating can protect the cargo in
the stomach, and that the underlying mucoadhesive coating still works after the
enteric layer has dissolved. This multifunctional GLP-1 delivery system resulted
in a 32% reduction in blood glucose levels and a 6-fold enhancement in pancre-
atic insulin content, as compared to the pure GLP-1 + DPP4 solution, when stud-
ied in vivo with a type 2 diabetic rat model.
The benefit of iv administration is the 100 % bioavailability, but the prob-
lem of rapid clearance from the blood circulation is the biggest stumbling block
of this delivery route. De Rosa et al. found that agarose coating protected the bo-
vine serum albumin (BSA) which was loaded on PSi microparticles [108]. In our
study (Paper III), PSi nanoparticles were sustaining the release of PYY, but the
release was still significantly faster compared to sc administered nanoparticles.
This was attributed to faster dissolution of peptides in circulation caused by com-
petitive adsorption of blood proteins. One interesting, but less studied branch of
peptide delivery is the use of PSi particles as vaccine adjuvants and an antigen
delivery device. Microparticles might have an active role in vaccines as a substi-
tute of pathogen-associated molecular patterns (PAMPs), which are used in an-
tigen based, subunit vaccines. Indeed, it has been shown that antigenic peptides,
delivered with PSi microparticles, enhances MHC class I presentation by human
monocyte derived dendritic cells to CD8 T lymphocytes [109].
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3.2 Stabilization of amorphous drug form
Since the first study on ibuprofen delivery with MCM-41 microparticles [110] in
2001, the most studied drug delivery application of mesoporous materials has
been the  delivery  of  small  molecule  drugs.  This  has  been shown to  work also
with PSi films [111] and PSi microparticles [67].
The value of the application is that the vast majority of new small molecu-
lar entities for oral administration suffer poor bioavailability arising from poor
aqueous solubility [112]. The amorphization is a promising tool to overcome the
dissolution issue, but the stabilization of the amorphous form is challenging [113].
Salonen et al. [67] found that the release rate depends on the type of the drug, PSi
increases the solubility of poorly soluble drugs and decreases the solubility of
already soluble drugs. This has been attributed to two different phenomena. For
drugs with good solubility, the long pores with relatively large surface area are
slowing dissolution and diffusion of the drugs. In case of poorly soluble drugs,
the enhanced dissolution has been attributed to the amorphous state of a drug
caused by the confined space inside the pores [114,115].
The better dissolution of poorly soluble drugs has been mostly studied in
vitro, but one of the rare exceptions has been made by Wang et al., who studied
the  effect  of  enhanced dissolution to in vivo absorption [116]. They used indo-
methacin as a model drug because its oral permeability is high, but its dissolution
hinders the bioavailability. They found that oxidized PSi microparticles were
able to increase the bioavailability of a drug to 100 % when it was 54 % for the
pure drug and 77 % for the commercial formulation Indocid. In addition, they
found excellent in vivo–in vitro correlation between dissolution experiments and
absorption.
3.3  Passive and active targeting
The most recent application of PSi particles has mainly emerged after the size of
particles was decreased into the nanoscale,  which enabled the intravenous ad-
ministration and tumor targeting [69,70]. This is probably the most studied ap-
plication among all pharmaceutical nanoparticles because of the enhanced per-
meability and retention (EPR) on tumor vasculature [117]. This natural ability of
tumor tissue to absorb nutrients from circulation makes it possible to accumulate
nanoparticles to the tissue if long enough circulation time is achieved. The big-
gest threat for long circulation is mononuclear phagocyte system (MPS) which
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includes liver, spleen, lungs, and bone marrow. The avoidance of this system has
been an issue of nanoparticle based drug delivery for more than 30 years [118].
To some extent, nanoparticles can avoid the recognition of immune system (op-
sonization) and subsequent phagocytosis of macrophages in MPS organs via the
steric stabilization [119]. Steric stabilization is typically achieved with a neutrally
charged and hydrophilic polymeric coating. One of the first nanodrugs on mar-
ket, Abraxane, licensed in 2005 for the treatment of refractory malignant breast
cancer [120], is utilizing this kind of “stealth” coating. The conventional hydro-
phobic chemotherapeutic agent paclitaxel nanoparticle is covered with albumin,
which  is  the  most  common  protein  in  circulation  and  thus  works  as  a  Trojan
horse in the system.
Despite  the  significant  efforts,  long  circulation  time  has  been  hard  to
achieve with pure tuning of the surface chemistry of PSi nanoparticles [121–123].
Instead, some evidences has been found that the particle shape and size might
affect the distribution [124]. Especially promising are disc shaped particles which
seem to interact with neuroblastoma cells and accumulate into the tumor [76,77].
The exploitation of the EPR effect on targeting nanoparticles is typically
referred as passive targeting. The use of specific molecular markers to deliver the
cargo to the site of action is called active targeting. The marking can be made
with antibodies [125,126] or peptides [127–129] which are overexpressed on the
surface of target cells. These markers can also enhance the cellular uptake [130]
and this way facilitate the delivery of active molecules inside the cell. Here, the
probability of adsorptive endocytosis might further increase with positively
charged surface chemistry [131,132], but a lot of different interactions need to be
considered before that.
3.4 Other delivery routes
Besides oral, sc, and iv administration routes, a few other interesting ways to use
PSi  in  treatment  of  diseases  have  been  studied.  Actually,  one  of  the  most  ad-
vanced biomedical application of PSi particles does not include the drug at all,
but biodegradable and 32P isotope containing PSi microparticles are placed with
injection directly into the tumor [133]. In this, so called brachytherapy, the aim is
to keep the radioactive source bound in the particle inside the tumor and this
way expose the surrounding healthy tissue to a minimum amount of radiation.
The phosphorus 32 isotope is close to the ideal therapeutic radionuclide due to
the long, two-week half-life and positron emitting decay. After promising in vitro
results [66], the development was carried on with human patients [134], which
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followed Phase IIa clinical trials [133]. The data from clinical studies showed
doubling overall survival rates compared to standard care. Approximately half
of the patients were alive after 18 months, whereas typically more than 80 % of
patients die during 12 months. This technology was developed by pSiMedica and
is now licensed to OncoSil Medical Limited under the trademark OncoSil. During
the writing of this thesis, the FDA has just accepted global pivotal studies under
IDE  (investigational  device  exemption),  and  the  approval  of  CE  mark  for  the
commercial launch is awaited in UK, EU, and Australia6.
Another delivery route of PSi is the intravitreal delivery. In order to treat
retinal diseases such as age-related macular degeneration and proliferative vit-
reoretinopathy, there are many difficult to reach drug targets inside the eye. Sus-
tained release DDSs are needed because frequent injections into the eye are ex-
pensive and lowers the patient compliance rates. Sustained release from PSi par-
ticles or films has been achieved in intravitreal delivery with covalent bonding
of a drug and subsequent degradation driven release [135], for example.
The  possibility  to  exploit  of  the  tunable  fabrication methods  and optical
properties and the visual monitoring of the drug release during the treatment, is
a benefit of PSi based DDS [136,137]. The flexible fabrication techniques are also
exploited in another emerging application. Chiappini et al. have [138,139] re-
cently developed PSi nanoneedles with precise microfabrication techniques and
metal assisted chemical etching for highly localized delivery of nucleic acids or
quantum dots.
6 Oncosil Investor Presentation - Aug 2016 (22.8.2016). OncoSil Medical announce-
ments can be found on the Australian Stock Exchange (www.asx.com.au) under the
code “OSL”.
4 Characterization and properties of
mesoporous nanoparticles
4.1 Dry state properties
The complex and variable structure of PSi provides a variety of physicochemical
properties  but  is  a  challenge  for  characterization at  the  same time.  Few of  the
most influential techniques for the study of PSi include electron microscopes
(EM), nitrogen sorption, Fourier transform infrared spectroscopy (FTIR), and X-
ray photoelectron spectroscopy (XPS).
The main advantage of EM measurements is the direct characterization of
PSi morphology in micron-scale and nanoscale [140]. Especially important has
been the scanning electron microscope (SEM). The knowledge of the fabrication
parameters’ impact on the final structure of PSi has significantly increased along
with the development of better imaging techniques, such as SEM (Figure 3). The
drawback of electron microscopes is the small statistical significance. In a typical
cross section image, there might be 50 pores in a 1 µm row, but when the whole
sample is macroscopic, 1 cm2 for example, there is in total 250 billion pores.
A powerful way to overcome this issue and to characterize porous materi-
als is gas sorption. If the previous mentioned sample is 10 µm thick and the pore
diameter is 15 nm, the amount of surface area in the pore walls is more than 1000
times bigger than the apparent 1 cm2 surface area of the sample. With the gas
sorption method, the actual surface area in a sample is determined by utilizing
the  affinity  of  gas  molecules  (typically  nitrogen)  to  the  surface  of  material.  By
measuring precisely  the  volume of  injected gas  and pressure  on the  test  tube,
adsorption of the gas molecules can be observed, and with predictions from the
Brunauer-Emmet-Teller (BET) theory, the surface area can be calculated [141]. By
continuing the gas injection into the sample tube near ambient pressure (and near
the condensation temperature of nitrogen), the capillary effect eventually fills the
pores with liquid nitrogen. When the gas pressure is decreased during the so
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called desorption branch, the capillary effect causes a hysteresis loop to form in
the adsorption-desorption isotherm. From the shape of this loop (Figure 8), the
pore morphology, as well as pore size, can be determined [142]. One of the most
used theories for the determination of pore size distribution is the so called Bar-
ret-Joyner-Halenda (BJH) theory [143].
Figure 8.  Shape classification of gas sorption isotherms. The hysteresis loop, especially
in IV, is usually associated to the filling and emptying of the mesopores by capillary con-
densation. Image is Donohue’s adaptation [144] from IUPAC’s classification [145]. Re-
printed with permission from Elsevier (© 1998).
Thermal analysis and calorimetry provide a way to characterize PSi, espe-
cially for drug delivery purposes. Thermogravimetry (TG) measures the amount
of  mass  loss  during heating,  and as  the  loaded drug usually  decomposes  and
desorbs completely at high temperatures (< 700 °C) the mass loss can be used for
the estimation of the loading degree [146,147]. In differential scanning calorime-
try  (DSC),  the  energetics  of  phase  transformations  are  studied  and  the  drug’s
physical form inside the pores can be determined. This has opened new insights
to various amorphous forms of drugs inside the pores [115,148] and shown the
importance of well controlled drug loading since the crystallization to the exter-
nal surface of particles is undesired [149].
A convenient way to analyze the surface chemistry of PSi is the infrared
spectroscopy (IR) or Fourier transform infrared spectroscopy (FTIR). Although
silicon absorbs light strongly in the shorter wavelengths of the visible spectrum,
it is almost transparent in the IR area. In addition, the high surface area assures
the sufficient concentration of surface groups when the surface species, Si—H
and Si—O, are characterized [150].
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4.2 Medium dependent characterization
The problem with all previous mentioned techniques is that they are not com-
patible with wet samples. When nanoparticles are placed in an aqueous medium,
the system changes from a static material studied in vacuum without “context,”
to a dynamic part of the bigger system. Constant thermal motion of the medium
keeps particles in motion in such a vigorous way that colloids with small enough
particle size (and a few other limitations, as will be seen) can be considered stable.
In this context, stability is considered a stability against gravitation, sedimenta-
tion, or in some cases, against agglomeration.
The physics in the world of nanoparticles has been studied long before the
term nanoscience was even known. Many different disciplines, physics, chemis-
try, mathematics,  and biology, have contributed to building the models of the
nanoscale world. Unfortunately, the discussion between these fields has turned
out to be challenging at times and many overlapping definitions are confusing
the field. These models concern different kinds of forces, which are manifested
in different ways depending on the length scale. Forces can be divided into long-
range and short-range categories (Table I), where the latter typically means forces
affecting less than 1 nm distance from the surface. In the case of nanoparticles,
especially when stability issues are considered, the long-range forces are more
important.
One of the earlier attempts to shine a light to the world of nanoparticles or
colloidal particles was made in the field of colloidal sciences. These models are
especially beneficial for the studies of nanoparticles because they mostly consider
the long-range forces. Many of the theories are well known, but they are not usu-
ally included in the curriculum of the physics master’s studies. Nevertheless, I
have found these concepts useful so we will shortly go through a few of the main
phenomena dominating the surroundings and interactions of nanoparticles. The
introduction to these concepts in Chapters 4.2.1-4.2.5 is obtained from the several
text books considering surface charging and zeta potential [15,151,152], stability
against agglomeration and long-range colloidal forces [15,153], Brownian mo-
tion [154], light scattering [155–157], and isotonic solutions [158].
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Table I. Different types of interparticle forces in liquidsa*
Type of the
Interaction
Other Names (subclasses) Attractive or Re-
pulsive






Either: attractive Weak but ubiquitous body force.
Force can change sign at some finite
distance.






Strong, long-ranged force arising in
polar solvents. Usually a surface
force.




Surface force that modifies the local
liquid structure
Entropic Steric, osmotic, thermal fluctuation,
polymer brindging, depletionb, dou-
ble-layerb
Usually repulsive Surface force that arises from the con-
finement of solvent or solute mole-
cules between the surfaces
Short-range
physical
Adhesive, cohesive, surface tension,
wetting, capillary
Usually attractive Can be either a body or surface force
Short-range
chemical
Covalent, quantum mechanical, me-





Strong short-ranged surface forces,
largely independent of the suspend-
ing liquid medium
Specific Complementary (electrostatic or geo-





Single or multiple noncovalent bond
arising from perfect fit of ion or mol-
ecule into host pocket or lattice site.
Nonequilib-
rium
Viscous (drag), friction, shear, lubri-





Involves continuous or transient mo-
tion of molecules or particles. Heat
generating.
a Unless specifically mentioned, the interactions refer to the pair-potentials of like particles.
b Forces that are difficult to classify unambiguously, or that are made up of two equally important contributors
c Classification still unknown or controversial
* Reprinted from [159] with permission from Elsevier (© 2011)
4.2.1 Surface charge and zeta potential
A polar medium, such as water, leads to the rise of surface charging of a particle,
even if the surface is neutral in the dry state. This is typically caused by the ioni-
zation of the surface groups, uneven ion adsorption from medium, or uneven ion
dissolution on a particle surface. The most relevant surface charging mechanism,
in our point of view, is ionization, which in many cases is pH dependent. The pH
point  where  the  average  surface  charge  is  neutral  is  called  the  point  of  zero
charge (PZC). This is very easy to confuse with the isoelectric point, which actu-
ally means almost the same thing for proteins, but in the case of nanoparticles,
the situation is different. Proteins’ charge is mostly caused by amine (e.g. —NH3+)
or  carboxyl  groups  (—COOH),  and the  point  where  the  total  charge  is  zero  is
called the isoelectric point (pI). In the case of nanoparticles, the isoelectric point
(IEP) is defined as pH value, where zeta potential goes to zero. Luckily, the ab-
breviations for these physical quantities are typically different and hereinafter,
the (calculated) isoelectric point of proteins or peptides is abbreviated as (pI) and
(measured) isoelectric point in the case of particles as (IEP).
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Zeta potential is a quantity that is defined as movement of the particle un-
der the applied electric field in a (electrolyte) solution. As stated above, all parti-
cles have surface charge ( ) which means that they also have surface potential
(Ψ ). These properties are causing their movement under applied electric field.
In the presence of a polar medium and ions, the so called electrical double layer
(EDL) is formed around the particle as a consequence of uneven distribution of
free  charges  around  the  charged  particle  in  solution  (according  to  the  Gouy-
Chapman model). In addition, some counterions are adsorbed transiently, or
specifically on the surface, which causes the formation of a Stern or Helmholtz
layer. Potential on the surface, right next to the adsorbed layer, is called Stern
potential (Ψ ) (Figure 9). In a technical point of view, the actual surface charge
behind the layer of tightly attached adsorbed ions cannot be distinguished when
the measurement is electrokinetic, i.e. by measuring the movement of the particle
under the applied electric field. Stern potential is typically very close to this so
called slipping plane, but in order to make a difference between these planes, the
electrokinetically obtained quantity is called zeta potential ( ).  Because  of  the
zeta potential’s sensitivity to adsorption, it is a compelling research method for
the characterization of charged molecules such as peptides and proteins  [160].
Figure 9. Two possible, but not the most typical, scenarios on what happens to electric
potential as a function of distance from the surface when (a) polyvalent counter-ions and
(b) surface active co-ions are adsorbed. Dashed line represents the Stern plane in average
distance of adsorbed ions and zeta potential (z) is the electrokinetically measured quan-
tity on its own slip plain. Reprinted from [152] with permission from Elsevier (© 1994).
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4.2.2 Diffusion
When studying pollen particles under the microscope, one will clearly see a phe-
nomenon dictating the wet world of nanoparticles. Particles are under constant
movement. This was observed also by botanist Robert Brown in 1827, after whom
the phenomenon was named as Brownian motion. Later the motion was ex-
plained by the constant random impacts caused by thermal motion of molecules
in solution. Because these collisions are random, the average movement of many
particles is zero, but for one particle the movement, diffusion, can and will hap-
pen. According to Einstein and Smoluchowski, the displacement ( ) can be de-
scribed by the simple relationship
〈 ( ) 〉 = (1)
Here  is diffusion coefficient (or constant),  is time and ( ) is the particle dis-
placement vector. When a particle is suspended in a medium, viscosity causes a
movement-opposing force and the translational diffusion coefficient  can be
described with the Stokes-Einstein equation
= 6 (2)
where  is Bolzmann’s constant,  is temperature,  is the medium viscosity
and  is the hydrodynamic diameter of the moving object. This way, by observ-
ing the movement of particles in solution, with known temperature and viscosity,
it is possible to calculate particles’ translational diffusion coefficient and get the
value  for  the  hydrodynamic  diameter.  Because  the  hydrodynamic  diameter  is
calculated from the movement of the particle, it is only a close approximation of
the actual particle size. This is an analogue to zeta potential and surface potential.
In the Stokes-Einstein equation, a few approximations are made and one of them
is that the particle is assumed spherical and rigid. In other words, the hydrody-
namic diameter describes the diameter of a spherical particle, which has the same
diffusion coefficient as the studied particle. Another similarity with zeta poten-
tial is that the adsorbed layer moves with the original particle and thus affects
the diffusion.
4.2.3 Biorelevant and pharmacorelevant fluids
In biological applications, the prediction of nanoparticle behavior gets complex.
There is, for example, enormous selection of biomolecules that are circulating in
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our veins. Biological molecules are typically big and flexible, which means it is
likely that there are parts that favor surface interactions. In addition, there are
more combinations of physicochemical properties that are promoting adsorption
than restraining it [161]. Some predictions can be made when we know the hy-
drophobicity and the charge of the surface,  and the protein. Hydrophobic sur-
faces typically attract proteins and so do the oppositely charged surfaces. Protein
labile structures can also increase the probability of adsorption.
Another compelling property of a biological fluid is its osmotic pressure,
which due to the ions present all over the body, is quite high. Osmotic pressure
is important because the cell membrane acts as a semipermeable membrane. It
allows water molecules to diffuse freely through it,  which means that osmotic
pressure tends to seek a balance on both sides of the membrane. If osmotic pres-
sure is higher outside the cell, the solution is hypertonic and water starts to flow
out causing the cell to shrink. This kind of solution typically contains too much
salt, or the drug concentration is high. The solution with too low an osmotic con-
centration  is  called  hypotonic,  and  it  results  in  water  flow  into  the  cell.  This
causes swelling of the cell and in extreme cases lysis, braking of the cell mem-
brane. When the solution is compatible with cells in terms of osmotic pressure, it
is called isotonic. Tonicity, as a term, differs from osmotic pressure because the
situation is not as simple as explained in all cases. There are some substances that
diffuse through the cell membrane which complicates predicting behavior of the
cell.
Since osmotic pressure cannot be readily measured, it  is  often character-
ized by connecting it to freezing-point depression. Freezing-point depression of
the well-known isotonic saline solution (0.9 % NaCl) is 0.52 °C. By finding the
same freezing point depression, the unknown isosmotic concentration of the so-
lution can be determined [162].
4.2.4 Stability against agglomeration
The long-range interactions, van der Waals interaction, and double-layer inter-
action (or electrostatic force) are dictating the stability of colloids according to
theory, described by Derjaguin and Landau [163], and Verwey and Over-
beek [164]. This, so called DLVO theory, explains the stabilizing effect of usually
repulsive double-layer interactions against the attractive van der Waals interac-
tions (Figure 10). The net DLVO interaction forms a primary minimum near the
surface, and if the charge is high enough, an energy barrier is formed right out-
side the minimum. In certain cases, a secondary minimum can also appear far-
ther away from the surface. Secondary minimum typically causes the agglomer-
ation of the particles. In this work, we follow the proposal of Nichols et al. [165]
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that agglomeration means the attachment of the particles in a reversible and eas-
ily dispersible manner, as is the case with this secondary minimum. Aggregation
is  instead  a  strong  (and  even  chemical)  interaction  which,  is  impossible  to  be
break without extreme force.
Figure 10. Interaction energy of two approaching surfaces (inset) as a function of distance
as  modeled  by  DLVO  theory.  Reprinted  from  [153]  with  permission  from  Elsevier (©
2011).
In  simple  solvents  and  electrolytes,  the  DLVO  theory  satisfactorily  de-
scribes the stability of colloidal solutions, but in a more complex solution, if there
is longer polymers on the surface, or if the surface is hydrophobic, the stability is
not as much a straightforward phenomenon. In this case, the most relevant group
of interactions affecting stability are solvation forces. These forces depend on the
properties of the surface but also the medium. In this context, the most important,
well studied, and unknown phenomenon is hydrophobicity, the strongly repul-
sive force between certain kind of surfaces and water molecules. Hydrophobicity
has originally meant the low solubility and unexpectedly strong interaction be-
tween hydrocarbons in water. Hydrophobicity was extended to surfaces, when
it was discovered that the mutual interaction between two surfaces could be
higher than van der Waals forces predict, and water droplets have a large contact
angle on hydrophobic surfaces. The latter gives an easy way to estimate the hy-
drophobicity by measuring the contact angle between surfaces and water drop-
lets.  When the angle is high enough (> 90°)  the surface is generally considered
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hydrophobic, although different definitions can be found depending on a re-
search field.
The hydrophobic effect and insufficient electrostatic repulsion can both
lead  to  unstable  colloidal  suspension  in  water,  which  can  be  avoided  with  so
called steric stabilization. This typically means that the attachment of hydrophilic
polymers or proteins to the particle surface changes the surface interaction with
the surroundings in a more solvent favoring direction. Hydrophilic large mole-
cules form a “hairy” layer around the particle, and when these layers are over-
lapping while two particles are approaching each other, they are causing a repul-
sive force.
4.2.5 Light scattering
Dynamic light scattering (DLS) makes use of the light’s tendency to reflect or
refract when travelling through interfaces of two phases with different refractive
index. In the case of colloidal particles, this phenomenon is called light scattering.
When the measurement is made in certain angle, light intensity either increases
or decreases depending on the position of adjacent scattering objects. If particles
are in constant movement, which is the case in colloidal suspensions, the very
fast intensity fluctuations occur and the phenomenon is called DLS. Since the
intensity fluctuations arise because of the Brownian motion of nanoparticles, it
enables the convenient determination of the translational diffusion coefficient
(equation 2). This way, the average size or even size distribution of nanoparticles
is possible to be determined.
The measurement of fast intensity fluctuations and calculation of diffusion
coefficients from obtained data is not a straightforward task, and DLS has bene-
fitted from the recent technological advancements. These are, for example, the
development of the digital autocorrelator, fast and cheap CCDs, and lasers, as
well  as the increase of calculation power from computers.  The benefits of new
DLS instruments include fast and non-invasive measurements and statistically
significant results.
The direction of scattered light depends on the size and shape of the scat-
tering object. As a rule of thumb, the bigger the particle is, the more it scatters
light forward. In the so-called Rayleigh scattering zone, the size of the particle is
much smaller than the wavelength of incident light ( < 20⁄ ), and the angular
dependence disappears. When operating above the Rayleigh regime, the light
scattering is rigorously explained by the Mie theory. In this regime, the close rel-
ative of DLS is so called static light scattering (SLS). With this technique, the an-
gular pattern of time averaged scattered light is collected and from the results,
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the particle shape and size can be determined. Both of these light scattering tech-
niques, DLS and SLS, give a different kind of approximation for particle size, and
comparing them may be beneficial.
4.3 Importance of biorelevant physicochemical properties of PSi
The balance between nanoparticles’ toxicity and functionality are a delicate mat-
ter in DDSs. A good example of this is that on the one hand, passively targeted
nanoparticles are trying to avoid the immune system and on the other hand, ad-
juvants for vaccine therapies are trying to activate it [166]. This highlights the
importance of understanding the effects of particle properties to the physiologi-
cal response. Walkey et al. [167] described the design of nanoparticles with two
different causal relationships: synthetic identity determines the biological iden-
tity, which in turn determines the physiological response (Figure 11). Synthetic
identity is defined by dry state properties like size, shape, and chemical compo-
sition and biological identity by wet state properties like hydrodynamic size, ag-
gregation, and protein adsorption.
Figure 11. Design and prediction cycle as proposed by Walkey et al. [167]. Figure adapted
with permission from The Royal Society of Chemistry.
4.3.1 Biodegradation of PSi
Besides the calcification, Canham et al. observed biodegradation of PSi [31,168],
which was soon noticed to depend on the porosity and pH [169]. The finding was
encouraging because of the fact that the degradation product of silicon is silicic
acid  [170].  This  is  the  most  common  form  of  silicon  in  humans  and  has  been
found to be an essential nutrient [171,172]. Although silicic acid has been shown
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to be absorbed by the gi tract, it is also rapidly excreted via the urinary pathways
and does not accumulate in the body [173].  There is some evidence that silicic
acid may have some additional health benefits, e.g. against Alzheimer’s dis-
ease [174].
The degradation of PSi in biological environments (biodegradation) is ra-
ther well studied property. Besides higher pH increasing the dissolution rate,
Anderson et al. [169] noticed that the lowest dissolution took place in a low po-
rosity (62%) film, but surprisingly the film with medium porosity (83%) dis-
solved more during 24 h than the film with the highest porosity (88 %). So, the
dissolution was not increasing monotonically as a function of porosity, and the
difference was attributed to the film microstructure. The more recent studies on
biodegradation of PSi microparticles attribute the faster dissolution to larger pore
size [45,108,175]. Another structure related parameter is, naturally, the dimen-
sions  of  the  studied  sample.  The  time  of  biodegradation  could  vary  from
days [108] to hours [69] when the particle size is decreased from the micronscale
(~3 µm) to the nanoscale (~130 nm). This is understandable, since the concentra-
tion of silicic acid in saturated solutions is not high (~100 µg/ml), and the diffu-
sion of the degradation products inside the porous matrix is slow. This was ob-
served already by Anderson et al. [169], when they noted that dissolution seems
to take place only on top of PSi layer.
The chemistry of PSi surfaces has a significant role in biodegradation. In
biomedical applications, the freshly etched (as-anodized) hydrogen terminated
surface turns into a native oxide surface when exposed to water. This surface is
more  stable  than the  as-anodized surface  but  in  many cases  degrades  still  too
fast [69]. Conveniently, the diverse surface treatment arsenal enables the produc-
tion of more stable surfaces for biomedical applications. When the degradation
of PSi microparticles was studied in intravitreal gel inside rabbit eyes [136], the
big differences were found between different surface chemistries. As-anodized
particles degraded completely in a month, whereas thermal oxidation doubled
the degradation time. In the case of hydrosilylated particles,  only half of them
were degraded when the experiment ended after four months. Jalkanen et al. [44]
studied the degradation of multilayered PSi optical structures with different sur-
face treatments in a strongly alkaline 1 M NaOH solution. Hydrosilylation pro-
tected the surface for 2-3 hours if the surface was hydrophobic (decene termi-
nated). Hydrophilic (undecylenic acid terminated) surfaces did not differ signif-
icantly from thermally oxidized surfaces, and the structure was completely dis-
solved in less than 10 minutes. The best degradation resistance was on thermally
carbonized samples, which started to show some signs of distortion after 5 hours
but needed approximately 14 hours to dissolve completely.
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The fact that the dissolution mechanism (Figure 12) is strongly pH depend-
ent is important in the biological point of view since the typical pH inside human
systemic circulation is slightly basic at a pH of 7.4.  In addition, increasing the
temperature from laboratory conditions to body temperature (37 °C) accelerates
dissolution [169]. It has been observed that proteins (FBS, Fetal Bovine Serum)
might also accelerate the degradation of PSi microparticles [45]. Tzur-Balter et al.
noticed that, for example, a tumor microenvironment affects the degradation of
PSi microparticles, which they attributed to increased oxidative stress compared
to healthy tissue. In the summary, they also highlight the need to study the ma-
terial performance in the right context [176]. When the behavior of the material
can be tested in relevant conditions, the degradation can be tuned by adjusting
surface coatings with PEG [45] or dextran [69], for example.
Figure  12.  Proposed  mechanism  for  porous  silicon  degradation  in  aqueous  solu-
tions [170]. (a) A Si—H-terminated surface immersed in H2O. (b) The Si-H bond under-
goes hydrolytic attack and is converted to Si—OH and produces a hydrogen molecule.
(c) The Si—OH at the surface polarizes and weakens the Si—Si backbonds, which are then
attacked by H2O, producing HSi(OH)3. (d) In solution, the HSi(OH)3 molecule is quickly
converted to Si(OH)4 releasing a second hydrogen molecule. Figure has been redrawn
and reprinted from [177] with permission of Springer International Publishing Switzer-
land (© 2014).
4.3.2 From PSi biocompatibility to biointeractions
Besides the PSi biocompatibility with bone, PSi has been found to be compatible
with the subcutaneous tissue of guinea pigs [178] and conjunctiva in rat
eyes [179]. On rats’ abdominal walls, PSi implants induced foreign body reac-
tions  comparable  to  the  response  of  the  well-known  bio-inert  material  tita-
nium [180]. PSi films have been found to be good substrates also for cell adhesion
and culturing [181,182], although surface chemistry can affect the cell attachment
and growth [183] as well as the denaturation of some proteins [99,184].
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The general target of biocompatibility studies for biomedical nanoparticles
is to be able to predict their pharmacokinetics, biodistribution [185,186], and tox-
icity [187]. The possibility to modify nanoparticles’ physicochemical properties
leads to rapid expansion of the available combinations, and the study of all these
would be time- and resource-consuming. Nanoparticles’ interplay with cells is
one of the most determining factors in inflammatory responses, biodistribution,
and toxicity in vivo [188,189]. This interplay is mediated by different interfaces
which Nel et al. divided into two different categories: the quite well known solid-
liquid interface (which properties are presented on chapter 4.2) and the less
known and far more complex nano-bio interface, where the final interaction be-
tween nanoparticle and cell surface happens [190].
The role of electrostatic interactions on cellular uptake has been studied in
many reports, and the importance of high absolute zeta potential for cell uptake
has been observed [191–194]. This has also been noticed in toxicity studies where
a strong interaction of particles with the cell  membrane might induce toxic ef-
fects  [190].  The  same behavior  has  been observed with  PSi  nanoparticles  with
significant  surface chemistry dependent differences in toxicity [195]. The AP-
STCPSi nanoparticles with high positive zeta potential seem to cause the most
toxic effects, which is seen in several different indicators. Also, hydrophobicity
of THCPSi and UnTHCPSi particles caused cytotoxic signals. Hydrophilic and
negatively charged TOPSi and TCPSi nanoparticles rarely cause any toxicity. The
same was observed in in vivo studies with the exception that also THCPSi nano-
particles seemed to be bio-safe in addition to TOPSi and TCPSi.
The importance of neutral and hydrophilic surfaces has been recognized
when the target is to avoid the macrophages and create long circulating delivery
systems  [119].  Recently,  the  importance  of  the  collection  of  blood  proteins
around the nanoparticle, i.e., formation of so called protein corona, has been rec-
ognized, and the area is under expanding research efforts. Quite commonly, pro-
tein  corona  is  divided  to  hard  and  soft  corona  with  long  and  short  exchange
times [196–198]. The adsorption of hard corona proteins is typically also consid-
ered to be non-reversible (Figure 13) [199].
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Figure 13. Evolution and nature of hard (on left) and soft (on right) protein corona [199].
This is an unofficial adaptation of an article that appeared in an ACS publication. ACS
has not endorsed the content of this adaptation or the context of its use.
In the studies of protein corona, the hydrodynamic diameter and zeta po-
tential are playing a big role [198]. These measurements can readily give infor-
mation about the presence and size of the protein corona, but in order to produce
models for structure-activity relationship, more quantitative data about the com-
position of the corona is needed. Here the important instrument is a mass spec-
trometer, which is often utilized with liquid chromatography (LC-MS). Walkey
et al. [188] studied the protein corona “fingerprint” and cell association of 84 dif-
ferent gold and silver nanoparticle formulations in respect to particle size, sur-
face chemistry, and composition of the primary particle. From the results, they
developed a model that predicts the uptake and takes into account nanoparticles
properties and the protein corona fingerprint. The main finding of the study was
that  the  protein  corona fingerprint  predicted the  uptake  quite  well.  The  more
surprising finding was that despite the similar physicochemical parameters be-
tween two different materials, like size and surface chemistry, the composition
of primary particles was still an important factor. The uptake prediction model
that worked for gold nanoparticles could not predict the uptake of silver nano-
particles.  They also  noted that  despite  the  fact  that  nanoparticles’  exposure  to
serum causes zeta potential to shift to the average zeta potential of serum com-
ponents (which in this case was -7.8 ± 2.6 mV). Zeta potential was the most im-
portant physicochemical parameter affecting the composition of protein corona
and thus cell uptake.
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The importance of zeta potential to the cell uptake has also been observed
with PSi particles [132]. Serda et al. studied the uptake of PSi particles by endo-
thelial cells (HUVEC) and macrophages (J773) with and without serum on the
cell medium. Original zeta potential differences (-43 mv, 15 mv and -4 mV) were
levelled off (-32 mV, -40 mV and -28 mV) when serum was added on nanoparti-
cles. Curiously, addition of serum did not affect the uptake in the same way but
increased the differences between surface chemistries for both cell types.
The impact of the hydrophobicity of nanoparticles on protein corona for-
mation and composition is also significant. Increasing hydrophobicity increases
protein  affinity  to  the  surface  and  thus  the  density  and  thickness  of  the  co-
rona [167], but Zhu et al. [200] noted an inverse linear correlation between the
hydrophobicity index and cellular uptake. They treated gold nanoparticles with
albumin and noted that it  bound to the surface more tightly when the surface
was hydrophobic.  The avoidance of cellular uptake of hydrophobic nanoparti-
cles was attributed to this albumin binding ability. In his dissertation,
Rytkönen [201] studied the composition of protein corona around hydrophilic
THCPSi nanoparticles. It was found that hydrophilic coatings with PEG [122] or
hydrophobin [123] caused the amount of adsorbed corona proteins to decrease.
With hydrophobin, also the composition of the corona changed. In both cases,
the  binding  of  serum  albumin  decreased  when  the  surface  was  hydrophilic
which is in accordance with the previous mentioned results [200].
4.3.3 Size, agglomeration and dose
The need to study the agglomeration primarily arises from the importance of na-
noparticle size in biomedical applications [202,203] and toxicity [190]. The strong
size dependency has also been found from PSi particles, and, in agreement with
other  studies,  smaller  size  seems  to  promote  the  accumulation  of  particles  on
non-MPS organs [124]. In addition, the particles’ discoidal shape seems to en-
hance  size  dependence  of  observed particle  accumulation on breast  tumors  in
mice when compared to spherical silica beads [76]. Size dependent behavior and
subsequent toxicity for Caco-2 cells was observed by Santos et al. [204]. The cyto-
toxicity was studied in terms of mitochondrial disruption, ATP depletion, ROS
production, and cell  apoptosis.  The lowered toxic concentration threshold was
observed when particle size decreased from 75 µm to 1.2 µm. In a subsequent
study by Bimbo et al., the cytotoxicity was confirmed for small microparticles,
but when the size was decreased to an average size of 142 nm and 188 nm, cyto-
toxicity decreased [70].
One of the practical issues masking the impact of nanoparticles properties
to biological system is issues on dosing [205,206]. Firstly, the question of metrics
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is not as straightforward as one could expect because the proposed units, includ-
ing µg/ml, cm2/ml, µg/cm2 or particles/ml, all have their pros and cons, but in the
case of nanoparticles units cannot be easily converted. Other important and
closely related issues are nanoparticle dispersibility and colloidal stability. Parti-
cle agglomeration, which affects particle size distribution and may cause sedi-
mentation, depends on the medium and storing time.
Most of the toxicological studies consider a 24 hour time period, and dur-
ing this time, gold nanoparticles might change their form from dispersion of na-
noparticles (30 and 60 nm) to gel like macroscopic networks [207]. Another out-
come of agglomeration is sedimentation, which has been shown to cause toxicity
of nanomaterials in a cell culture medium [208]. On the other hand, the change
of size during the agglomeration can be also exploited, as demonstrated by Liu
et al. [209]  who  designed  particles  that  agglomerated  as  a  response  of  pH  de-
crease on tumor sites. This way, they enabled interaction between normally long
circulation particles and tumor tissue. Another positive impact of a biorelevant
medium  is  the  increase  of  the  stability  against  the  agglomeration  in  cell  cul-
tures [210,211], which may happen when hydrophobic nanoparticles are coated
with  proteins,  for  example.  The  effect  of  agglomeration  was  also  noticed  by
Sarparanta et al., with hydrophilic and slightly negatively charged hydrophobin
coated THCPSi particles [123]. They observed that the coating affects nanoparti-
cles’ colloidal stability in plasma, composition of protein corona, and biodistri-
bution. However, the differences in protein corona could not explain the nano-
particles’ different biodistribution, which was attributed to the change of size
consequent of agglomeration.
4.3.4 Adsorption, loading and release
The excellence of mesoporous nanoparticles over non-porous ones is in their abil-
ity  to  carry  and release  active  molecules  or  particles  with  different  sizes  from
small crystalline drugs [67] to bigger peptides [93], oligonucleotides [212], pro-
teins [213], and even to secondary nanoparticles [214].
One of the benefits of small molecular drug delivery inside PSi is the amor-
phous nature of the poorly soluble drug and consequent increase in dissolution
rate [115,148,215]. This behavior has been attributed to the physical confine-
ment [114] of drug molecules in the pores, which is naturally dependent on pore
dimensions. The pore size was noticed to have an effect on loading and release
in many studies. The bigger pores typically increase the loading and release
rate [175,214,216,217] with the limitation that the larger pore diameter may cause
recrystallization of the loaded drug [218]. When the aim has been to prolong the
drug  release,  it  has  been  achieved  via  smaller  pore  size  and  longer  diffusion
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length or by increasing the interaction between surface and drug molecules. If
the adsorption is irreversible or chemical, the release of the drug is controlled by
controlling the degradation of the carrier [135,219]. Here the surface chemistry,
and again pore size, are in major roles as explained before. As also stated before,
degradation of PSi depends on the pore size, particle size, and surface chemistry,
the same parameters that are also affecting diffusion [67,215,219].
Before going to loading experiments in more detail, it would be better to
define two concepts. The amount of drug compared to total mass of the formu-
lation ( . . , ( ) ( )⁄ )  is  called  the  loading  degree.  The  amount  of
loaded  drug  compared  to  amount  of  drug  available  in  loading  solution  (i.e.
( 	 	 ) ( 	 	 	 )⁄  is called the loading effi-
ciency.
The common strategy to achieve the optimal carrier properties with PSi is
to keep the pore size and particle size constant and adjust electrostatic and hy-
drophobic interactions between the surface and the drug molecules [90,220].
Tasciotti et al. studied the loading of so called secondary state nanoparticles into
PSi microparticles and observed improvement in loading when zeta potentials
of microparticles and nanoparticles were opposite [214]. The same observation
was made by Huotari et al. [221], when the loading degree of negatively charged
GLP-1 peptide in PSi microparticles was higher with positively charged surface
than with negatively charged surface. In addition, the loading degree decreased
from 45 % to 24 % when the pH was increased to 9.0, where the surface of origi-
nally positively charged PSi turns negative. By keeping the concentration of the
loading solution low, electrostatic interactions between the PSi surface and the
drug  molecule  might  also  enable  slower,  degradation  driven,  release  of  pay-
load [69].
Surface adsorption based loading is a tempting approach, especially with
biological cargoes when the molecules may be expensive and efficient use of the
carrying material is not that important an issue. Charged and hydrophobic sec-
tions in biomolecules typically enable the efficient loading (Figure 14), even
though the immersion method is used. As an example, Rytkönen et al. got a suf-
ficient 14 % loading degree with oligonucleotides [212] and Kovalainen et
al. [61,93] were able to load PYY with a 7 % loading degree, while both of these
loadings were made with a 100 % loading efficiency without waste of drug. More
basic research on the role of surface chemistry on protein adsorption onto PSi
surface has been done by Jarvis et al. [99]. They noticed that the hydrophobicity
of native porous silicon surfaces increased the adsorption of studied proteins (al-
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bumin, lysozyme, and papain) but also caused structural rearrangements. A hy-
drophilic oxide surface instead decreased the adsorbed amount of proteins, but
the protein structure remained undisturbed.
Figure 14. Surface modifications, peptide-surface interactions and biodegradation in pep-
tide delivery as explained by Kovalainen et al. [93]. Figure is constructed from the original
material with the permission of Dr. Riikonen.
The structural changes, when the driving force of biomolecule adsorption
is  a  strong  hydrophobic  interaction,  have  been  found  with  other  materials
also [222–224]. This kind of interaction is problematic in a drug delivery point of
view because of the possible denaturation of the drug molecule and irreversible
of adsorption [225]. Since the early studies on protein adsorption, it has been
known that in order to achieve maximum protein adsorption onto the surface,
maximizing electrostatic interaction between the surface and peptide is not nec-
essarily the best approach. The high charge of the adsorbate also increases the
repulsion  between  proteins  and  thus  decreases  the  packing  density  when  ad-
sorption happens [226] (Figure 15).
The same behavior has been discovered when loading biomolecules inside
mesoporous materials [227,228]. In an enzyme immobilization point of view,
Vinu et al. have  studied  the  adsorption  of  lysozyme  (pI ≈ 11) [227] and cyto-
chrome c (pI = 9.8) [229] into mesoporous (silica and carbon) materials. For both
peptides, the results were the same and the best loading capacity was observed
at pH near the protein isoelectric point. Later, Sang et al. calculated that the high
loading degree  on isoelectric  conditions  is  due  to  the  multilayered packing of
peptides in mesopores [228].
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Figure 15. pH dependent plateau adsorption of human serum albumin on negatively
charged polystyrene (PS) (∆), positively charged PS (▲), negatively charged silver iodide
(X) and uncharged poly(methylene oxide) (■). Reprinted from [230] with permission from
Elsevier (© 2005).
In summary, we have gone through characterization from the dry state to
the wet environment in this chapter. We have seen the importance of the “contex,”
the environment that the nanoparticles encounter and how it affects their behav-
ior. In order to make predictions, careful characterization with well-known meth-
ods is needed through the whole design process. This is a demanding task and
requires fluent collaboration between disciplines, starting from very basic re-
search, which has been emphasized in many writings lately [167,190,205,231]. In
the words of Zhang and Rosenholm on their editorial on Therapeutic Delivery
2015 [232]:
Changing the design for each paper for yet another proof-of-concept study will not
add significantly to this  body knowledge,  but more systematic  and mechanistic
studies on MSN behavior in conjunction to biological  systems toward deeper in
vitro–in vivo correlation  understanding  are  necessitated.  Adding  to  this  body  of
literature will facilitate timely translation of MSNs from bench to bedside.

5 Aims of the study
The general aims of this work were to evaluate the feasibility of PSi nanoparticles
on peptide delivery purposes and to study the use of light scattering as a charac-
terization method for these kind of studies. Under these main themes, the role of
medium and other formulation components were studied.
In the first paper, the objective was to study the zeta potential of PSi nano-
particles in isotonic formulations and to characterize the impact of peptide pay-
load on zeta potential.  The second objective was to test the zeta potential,  and
isoelectric point measurements on the PSi surface characterization purposes. The
surface chemistry characterization potential of zeta potential measurements was
utilized later in the second paper, where the aim was to enable and characterize
the amine functionalization of TCPSi.
Peptide loading into PSi nanoparticles, as well as the release of peptides,
was studied in the third and fourth papers.  The aim of the third paper was to
find out the suitability of PSi nanoparticles for sc and iv peptide (PYY3-36) deliv-
ery  and,  by  altering the  surface  chemistry,  to  understand the  effect  of  surface
chemistry  on peptide  release  rate  and bioavailability.  In  addition,  interactions
driving adsorption and loading of  peptide  (GLP-1)  into  PSi  nanoparticles  was
planned to study in fourth paper in order to find optimal peptide loading condi-
tions, and to find explanations for the behavior of PSi nanoparticles during in
vivo studies.
In the fifth paper, we wanted to explore the conventional light scattering
methods and how they can be used for more versatile characterization of nano-
particle properties, like size, stability, and porosity. The secondary aim of the
study was to understand why electron microscopy results sometimes differ dras-




6.1.1 PSi nanoparticle fabrication
PSi was anodized to boron doped p+-type Si-wafers with (100) orientation and
with a resistivity of 0.01–0.02 Ω cm (supplier Cemat Silicon or Siegert). A solution
of hydrofluoric acid (HF, 38%) and ethanol was used as an electrolyte with a 1:1
volumetric ratio. Electrochemical etching of a multilayer PSi film was carried out
by applying two different current densities successively. The lower etching cur-
rent density of 50 mA/cm2 was used as a work pulse to form a mesoporous struc-
ture for nanoparticles. This was followed by a high current density pulse of 200
mA/cm2, which is expected to lead to the formation of a brittle fracture layer in
between the mesoporous layers. After the higher current pulse, a brief pause was
applied to allow the stabilization of concentration gradients in the electrolyte.
The hydrogen terminated surface of the anodized PSi was stabilized using
three different surface treatments. Thermally oxidized porous silicon (TOPSi)
was obtained by heating the anodized films in air at 300 °C for two hours. Ther-
mal hydrocarbonization of PSi (THCPSi) was made in constant acetylene/N2 flow
at 500 °C. By continuing the treatment in acetylene/N2 flow at room temperature
(RT) and by subsequent annealing the material at 800 °C N2 flow, surface hydro-
gen completely dissociates, and thermally carbonized porous silicon (TCPSi) was
formed.
Further  functionalization  of  the  THCPSi  films  was  carried  out  by  cova-
lently attaching 10-undecylenic acid to the surface hydrocarbons. The fresh
THCPSi films were immersed in 120 °C undecylenic acid for 4 hours. The func-
tionalization of the TCPSi surface was made first, by immersing the films in an
etching electrolyte in order to create hydroxide groups on the surface and subse-
quently milling the films by using an APTES-toluene solution as the medium.
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These functionalized particles are referred to as UnTHCPSi and APSTCPSi, re-
spectively.
After the surface treatments, the freestanding PSi films were wet ball-
milled in a Fritsch Pulverisette 7. Ethanol was used as a grinding medium for the
UnTHCPSi, TCPSi and TOPSi films. In the case of APSTCPSi, the functionaliza-
tion was carried out during the milling in a 5-10 % APTES-toluene solution. With
THCPSi, particular attention was paid to avoiding oxidation by using 1-decene
as a grinding medium.
Fractioning of the nanoparticles from the polydisperse mixture of PSi and
grinding medium was done with a centrifuge. The diverse stability behavior aris-
ing from the different surface chemistries dictated the selection of the centrifuga-
tion medium. An attempt was made to keep the particle size distributions of the
PSi nanoparticles constant by altering the centrifugation parameters so that the
particle size distribution of the supernatant was within the desired limits. Typi-
cally centripetal accelerations from 1 500 g to 3 000 g were applied for the frac-
tioning and the supernatant was collected. The fractioning step was made several
times to the initial milled suspension and the collected supernatants were com-
bined. Significantly higher accelerations from 10 000 g to 17 000 g were applied
to discard the smallest particle fraction (< 100 nm), to concentrate the suspension
and to change the dispersion medium. During these washing steps, nanoparticles
were pelleted at the bottom of the tube and the supernatant was discarded. The
particles were redispersed with ultrasound when necessary, and ethanol was
used as a storage medium.
6.1.2 Silica nanoparticle fabrication
Silica nanoparticles were fabricated for Paper V in order to achieve more varia-
tions to pore morphology, orientation, and particle size. Syntheses were made
bottom-up via controlled nucleation and growth of silica structure around self-
assembled template of surfactants. Details of the syntheses conditions are tabu-
lated in Table II. In the case of hollow MSN, the synthesis details have been pub-
lished by Sen Karaman et al. [233]. In the case of P-MSN, pores are aligned paral-
lel to each other, while in R-MSN pores are radial, pointing towards the center of
the  particle.  With  H-MSN,  the  core  is  hollow  and  radial  porous  structure  is
formed on the shell.
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Table II. Summary of silica nanoparticles’ preparation conditions
Sample Base solution Additives Temp. Mixing Extraction Storing
S-SN EtOH/ammonia
TEOS+






















TEOS 20 mol% APTES 50°C








10 mol% APTES /
1.2 mol % Decane /






at 70◦C for 48h.
Calcination at
550◦C for 2.5 h. Dried
6.1.3 Peptide properties
The peptides used in experiments were the gastrointestinal peptides GLP-
1 (7-37) and PYY 3-36, later GLP-1 and PYY, which both are released endoge-
nously [234] and have promising applications in diabetes and obesity treat-
ment [235]. Two different versions of GLP-1 were used in these studies, which
causes a small difference in isoelectric (pI) points. In Paper I, pIs of GLP-1 and
PYY were calculated to be 5.4 and 7.7, respectively. In Paper IV, the acetylated
GLP-1 was used and the pI was at pH 4.6. Amino acid sequences of peptides are
shown in Table III.







The theoretical charge of amino acids in different pH values were calcu-
lated with the modified Henderson-Hasselbalch equation for positive (3) and
negative (4) amino acids [236]. Total charge of peptides was approximated by
summing  these  charges  together.  Amino  acid  dissociation  constants  were  ob-











6.2.1 Dynamic light scattering
On papers I, II, and IV, particle size was characterized by dynamic light scatter-
ing (DLS) measurements with the Malvern Zetasizer Nano ZS. The instrument
collects data at the one back-scattering angle of 178°. By optimizing the laser light
intensity and penetration depth to the suspension, multiple scattering can be
avoided and the concentration of suspension can be selected more freely. By an-
alyzing the autocorrelation function of collected intensity data, the diffusion con-
stant(s) of nanoparticles is measured. The non-negative least squares (NNLS) al-
gorithm [238] with a higher smoothing parameter, the so-called general purpose
mode, was used for the deconvolution of the diffusion constants’ distributions.
The CUMULANTS algorithm [239] was used for calculations of the average dif-
fusion constant.
The hydrodynamic diameter was calculated according to the Stokes-Ein-
stein equation (2). All the measurements were made in ethanol, with the excep-
tion of THCPSi nanoparticles which were measured in dimethyl-formamide
(DMF)  or  5  w% ethanoic  succinic  acid  solution.  These  media  were  selected in
order to stabilize THCPSi nanoparticles.
6.2.2 Multiangle light scattering measurements
In Paper V, multiangle LS measurements were made with Brookhaven Instru-
ment’s BI-200SM goniometer, a BIC-TurboCorr digital pseudo-cross-correlator,
and a BI-CrossCorr detector, including two BIC-DS1 detectors. Either a red or a
blue laser was used depending on the nanoparticles’ absorbance. In the case of
silica nanoparticles, absorption of visible light is low, but in the case of PSi nano-
particles, absorbance increases strongly when shorter wavelengths are used. The
unwanted effects of highly absorbing materials were minimized by using a red,
637 nm laser (A BIC Mini-L30 diode laser). In case of silica nanoparticles, a blue,
488.0 nm laser (Coherent Sapphire laser 488-100 CDRH) was used. LS measure-
ments were made from scattering angles of 30° to 150° with a 5° interval.
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In DLS experiments, pseudo-cross-correlation functions of scattered light
intensity were collected using the self-beating scheme [155]. Correlation func-
tions were analyzed with the CUMULANTS algorithm and a hydrodynamic ra-
dius  ( ) was calculated from  of nanoparticles according to the Stokes-Ein-
stein equation (2).
Temperature was set to 20 °C and controlled with a Lauda RC 6 CP ther-
mostat. Viscosity of methanol was 0.591 cP and refractive index was 1.332. The
effective hydrodynamic radius (R ) was measured at a fixed scattering angle ( )
and fixed mass concentration of particles ( ). The true hydrodynamic radius can
then be obtained by extrapolating R  to a zero angle and zero concentration.
Our experiments reveal negligible effect of particles’ concentration on  and
thus on R . Therefore, herein  refers to R  extrapolated to a zero angle.
SLS was used for determining the radius of gyration ( ) for the nanopar-
ticles. Normalized scattering intensity from the particles ( ), i.e. the scattering
function, is defined as
( ) = ( ) =
( )






is the scattering vector,  is the refractive index of the medium, and  is the laser
wavelength  in  vacuum.  In  other  words, ( ) is calculated by subtracting the
scattering of the medium from the total scattering intensity and normalizing this
value to the intensity at the extrapolated angle, = 0° . The Debye-
Bueche [240,241] or Guinier [242] scattering functions were found to be the most
suitable for  determination.
Pure solvents used in LS experiments were filtered with a 0.2 µm syringe
filter (Pall Acrodisc CR 13 mm with PTFE membrane). Cuvettes were first rinsed
with methanol and then dried in a filtered compressed air stream. In order to
reduce the adsorption of positively charged silica particles onto the negatively
charged glass surface, a cuvette was silanized with a 5 vol-% mixture of APTES
((3-aminopropyl)triethoxysilane) and toluene. Background scattering of the me-
dium, methanol, was measured and subtracted. Samples were diluted with
methanol to as low a concentration as possible in order to avoid agglomeration
and multiple scattering. The sample was drawn into a syringe and filtered with
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a 0.45 µm syringe filter (VWR International 13 mm with PTFE membrane) in or-
der  to  avoid dust  particles.  The  exception to  the  filtering step was  made with
bigger H-MSNs in which case the diluted suspension was used as it was.
6.2.3 Electrophoretic light scattering
The electrophoretic mobility of the PSi nanoparticles with different surface chem-
istries and nanosuspension media was measured with the electrophoretic light
scattering (ELS) method using the Malvern Zetasizer Nano ZS. Zeta potential, ζ,
was calculated from the electrophoretic mobility  with the equation
=
2
3 ( ) (7)
where the permittivity, , and viscosity, , are the properties of the medium, and
( ) is the so-called Henry’s function which depends on the particle radius, ,
and the Debye length,  [243].  The  Debye  length  can  be  understood  as  the
thickness of the electric double layer, which is inversely proportional to the ionic
strength [244].
The value of ( ) varies from 1.0 for low ionic strength and/or small par-
ticles to 1.5 for high ionic strength and/or large particle size.  Henry’s function
values for each medium were calculated with Ohshima’s approximation [245].




2 (1 + 2 )
(8)
Zeta potential characterization of a pure nanoparticle suspension was
made as a function of pH with the IEP titrations. The nanoparticle concentration
was 50 – 100 µg/ml, and de-ionized (DI) water was used as a medium. In Paper
II, IEP values were measured in a weak, 1 mM NaCl solution. HCl and NaOH
were used as titrants, and the addition of new ions to the nanosuspension was
taken into account in Henry’s function. Each data point is the average of at least
three individual measurements. The IEPs were determined by interpolating the




Peptide concentration measurements were made with an ultraviolet-visible (UV-
Vis) range spectrophotometer (Labrox, Finland). For the peptide loading experi-
ments, GLP-1 was dissolved in ultrapure DI water (Millipore Direct-Q 5 UV). An
ethanol based suspension of PSi nanoparticles was centrifuged, washed, and
changed to DI water. Loading experiments were made by combining peptide so-
lution, DI water, buffer solution, and a nanoparticle suspension, in this order, to
a 1.5 ml low retention Eppendorf centrifuge tube. After mixing, particle concen-
tration was 1 mg/ml and the buffer was diluted by half. Peptide concentration
was adjusted by changing the ratio of peptide stock solution and DI water. Ad-
sorption was let to equilibrate for 1.5 to 2 hours. Particles were centrifuged down
and the sample from the supernatant was applied to the well-plate for a UV ab-
sorbance measurement. All the measurements were made twice and average val-
ues with mean absolute deviations are reported. Statistical analysis with the In-
dependent-Sample T-Test was made with IBM SPSS Statistics 22.
Absorbance was measured at the wavelength of 280 nm, where peptides’
aromatic side chains phenylalanine (F), tyrosine (Y) and tryptophan (W) have an
absorption peak. Concentration dependence of the absorbance obeyed the linear
Beer-Lambert law after the proper reduction of the baseline caused by citric acid
in the buffer and occasional residues of PSi nanoparticles.
6.2.5 Nitrogen sorption
Specific surface area (SSABET) and pore volume (Vp) were obtained from the dried
nanoparticle samples with nitrogen sorption measurements (Micromeritics TriS-
tar 3000) at −196°C. The SSABET was calculated according to the BET theory [141].
Pore volume ( ) was calculated from the maximum nitrogen adsorption near
the  normal  pressure  [246].  If  necessary,  the  pore  diameter  ( ) was calculated
from these values by assuming cylindrical pores, when = ⋅ .
6.2.6 TEM
Size and shape of nanoparticles was analyzed with TEM (JEM-1400 Plus, JEOL
Ltd.) with 120 kV acceleration voltage. ImageJ 1.50 [247] was used for particle
analysis with following procedure.
The original 8-bit greyscale image was turned to binary scale by adjusting
the threshold with the “Threshold” tool. The threshold selection method was
fixed inside one particle batch, as the same thresholding method was impossible
to use on all  samples due to the contrast differences arising from the size and
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density of nanoparticles. Particles were selected with the “Analyze particles” tool.
The smallest particles ( < 400	nm , ≲ 12	nm)	were filtered out in order to
exclude the false particle identifications from the image noise and defects in the
supporting grid. In the case of silica nanoparticles, circularity measurement was
used in order to exclude agglomerates from the analysis. The complicated mor-
phology of the PSi nanoparticles made this method less convenient, and in this
case, the agglomerated particles were identified visually.
In order to retain comparability of TEM to LS measurements, all samples,
except H-MSN, were filtered with a 0.45 µm syringe filter (VWR International 25
mm with PTFE membrane).
7 Results
7.1 Nanoparticles used in studies (All papers)
For all papers, nanoparticles were characterized with ELS. One-angle backscat-
tering DLS measurements were made in Papers I, III and IV and multiangle DLS
in Paper V. For microparticles on Paper II, DLS is not a suitable method and the
particle size distribution was characterized by sieving ( ). The surface area and
pore volume were determined with N2-sorption measurements. Characterization
results are reported on Table IV and, in case of Paper V, on Table VI.
Table IV. Used nanoparticles (in Papers I-IV) and their characterization results
z Contact
anglenm µm mV m2/g cm3/g
Paper I
 TOPSi 132 0.120 2.6c
 THCPSi 129 a 0.167 a 4.6c
 UnTHCPSi 164 0.103 3.8c
 TCPSi 146 0.090 3.3c
 APSTCPSi 153 0.116 8.4c
Paper II
 TCPSi < 25 2.6d 256 0.87
 APSTCPSi < 25 7.7d 222 0.84
Paper III
 TOPSi 140 0.145 - 47.8e 163 0.591 15.3
 THCPSi 133b 0.158b - 40.5e 202 0.598 11.8
 UnTHCPSi 158 0.115 - 31.4e 230 0.706 12.3
Paper IV
 TCPSi 147 0.109 183 0.54 13° ± 3°
 APSTCPSi 166 0.055 9.0f 227 0.77 52° ± 5°
Used medium was DMF(a), 5 w% SA-EtOH(b), DI water(c), 1 mM NaCl(d), 10 mM phosphate buffer, pH 7.5(e),
1 mM NaH2PO4(f).
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7.2 Zeta potential as surface characterization method (Papers I, II,
IV)
In  order  to  study zeta  potentials  and IEPs,  the  PSi  nanoparticles  with  various
surface chemistries were fabricated. One aim of the study was to measure the
IEPs of these surface chemistries for the first time (Paper I). Titrations were made
with  several  different  nanoparticle  batches,  from  which  obtained  IEPs  are  re-
ported in  Table  IV.  Typical  titration curves  can be  seen in  Figure  16a.  For  the
peptide loading studies (Paper IV), the effect of McIlvane buffer to zeta potential
was measured and charge of GLP-1 peptides was calculated (Figure 16b).
Figure 16. (a) Titration curves for an IEP determination of PSi nanoparticles with different
surface chemistries (!) APSTCPSi (L) THCPSi (,)TCPSi (7)UnTHCPSi (B) TOPSi. (b) Zeta
potential of TCPSi (○) and APSTCPSi (◊) nanoparticles in different buffer solutions and
the calculated charge of GLP-1 peptide.
The lowest IEPs, 2.6 and 3.3, can be found from TOPSi and TCPSi, respectively.
The high treatment temperature of TCPSi enables the dissociated acetylene to
absorb into the PSi crystal structure, leading to the formation of a thin surface
oxide layer on the top of silicon carbide layer. The TCPSi and APSTCPSi surface
chemistries were later characterized with various methods in Paper II. The IEPs
for TOPSi and TCPSi are consistent with the IEP of silica, which is generally as-
sumed  to  be  in  between  of  2  and  3,  due  to  the  presence  of  surface  silanol
groups [248]. The observed differences between the IEPs of TOPSi and TCPSi
could be due to the differences in the surface oxide structure. Unexpectedly, IEP
results were also obtained for THCPSi nanoparticles. The surface of this material
is terminated by hydrocarbon groups [53], which cannot be ionized, thus a pH
independent behavior of surface charge should have been observed. However,
we managed to measure an IEP of 4.6 for the THCPSi in a repeatable fashion.
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This behavior could be due to the formation of surface silanol at the ball-milling
stage of PSi films.
IEP measurements also verified the successful functionalization of carbon-
ized surfaces. IEP was increased from 3.3 to 8.4 after the amine functionalization
of TCPSi. This was expected because the functionalization is typical for silica par-
ticles, and it is explained by the decrease of the number of free silanol groups and
by the presence of the primary amine groups on the surface [249]. Further con-
firmation of the result was obtained with IEP measurements of PSi microparticles
in Paper II. The smaller shift was observed when THCPSi surface was function-
alized  with  undecylenic  acid.  The  shift  was  explained  by  the  reaction  of  un-
decylenic acid with hydrophobic and neutral —CHx groups on the particle sur-
face. This means that these surface groups are reacting with the unsaturated end
of  the  molecule,  and the  carboxylic  acid  (—COOH) is  pointing outward.  This
yields a negatively charged and pH dependent surface termination.
In order to keep the pH constant during the peptide adsorption experiment
in Paper IV, McIlvane’s buffer solutions were used. Zeta potential is sensitive to
the ionic strength of the medium, which is why the nanoparticles’ IEP in buffers
was measured for the studied TCPSi and APSTCPSi particles (Figure 16b). When
compared to previously mentioned results in weak electrolytes, IEPs shifted
from pH 8.4 to pH 7.4 with APSTCPSi and from pH 3.3 to pH < 3.0 with TCPSi.
In addition, absolute zeta potential of both particles decreased throughout the
pH range and it  was especially pronounced in the case of APSTCPSi.  The fact
that  IEP shifted toward the  same direction with  both  surfaces  gives  reason to
suspect that some specific (non-electrostatic) adsorption of negatively charged
ions takes place on the buffer. Besides nanoparticles’ zeta potential, Figure 16b
also shows the theoretical net charge of GLP-1 in different pH conditions.
In Paper II, we showed that zeta potential measurements could be used for
in situ aqueous (chemical) stability studies (Figure 17). The loss of amine termi-
nation was studied with two different surface chemistries,  APSTCPSi and AP-
STOPSi, the former surface is thermally carbonized and latter thermally oxidized
before the silanization.
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Figure 17. Aqueous stability of zeta potential of APSTCPSi-10 in distilled water and in
pH 6.8 phosphate buffer and APSTOPSi-10 in distilled water as a function of time.
Zeta potential of all surfaces decreased as a function of time, which was
attributed to the detachment of the positively charged amine groups on the sur-
face. The APSTCPSi surface was found to be more stable against the degradation
as the detachment of the amine groups lasted several hours in the aqueous elec-
trolyte solution. The zeta potential of the APSTCPSi-10 decreases by 20 % from
its initial value in approximately 4 hours. Conversely, the APSTOPSi-10 ap-
peared to undergo a fast hydrolysis, and in the same time frame, zeta potential
was reduced by 70%. In a pH 6.8 buffer solution, the hydrolysis rate of APSTCPSi
increased when compared to the electrolyte solution. The PSi particles typically
cause an electrolyte pH shift to a slightly acidic direction, and in the buffer solu-
tion, pH 6.8 is significantly higher. Zeta potential decrease appeared to be slower
than with the oxidized sample, falling approximately 50 % from the initial value
in 4 hours, suggesting that the surface should be stable enough in aqueous con-
ditions to be used, e.g., in intravenous drug delivery applications.
7.3 Effect of isotonic media and peptide adsorption to zeta poten-
tial (Papers I, IV)
In order to study the effect of formulation components to zeta potential of a na-
noparticle suspension and its colloidal stability, nanoparticles were dispersed
into several different isotonic media (Figure 18) and nanoparticles’ zeta potential
was measured (Paper I). Zeta potential was found to be strongly dependent on
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the isotonic medium. The analysis of the results were made by keeping in mind
the practical | | > 30	mV limit for an electrostatically stable suspension7.
Figure 18. Zeta potential of PSi nanoparticles in different isotonic media.
As a highly basic compound, TRIS (2-Amino-2-hydroxymethyl-propane-
1,3-diol) caused the disappearance of special characteristics of the surface chem-
istries, with respect to zeta potential. Slightly acidic sucrose, dextrose and man-
nitol  generated a  good isotonic  medium for  negatively  charged nanoparticles,
but for positively charged APSTCPSi these additives reversed the zeta potential.
A somewhat unexpected result was the almost indistinguishable effect of PEG
300. Adsorption of neutral molecules on the charged surface should cause the
movement of the slip plane away from the surface causing a decrease of the ab-
solute value of the zeta potential [244]. The absence of this effect was attributed
to the small molecular weight of PEG molecule and the subsequent small shift of
the slip plane. HEPES (4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid)
shifted the zeta potential of TOPSi and UnTHCPSi slightly towards neutral but
maintained the zeta potential on a sufficiently high level. All salt solutions were
very  poor  media  for  PSi  nanoparticles,  because  the  high  ion  concentration
screens the surface charge and shifts the zeta potential practically to zero. The
more acidic solutions of citric and lactic acid maintain the positive zeta potential
of the APSTCPSi nanoparticles but are at the same time very poor media for neg-
atively charged particles.
In order to evaluate the role of loaded peptides on zeta potential of func-
tional nanoparticle drug delivery formulations (in Paper IV and in Paper I) and
to test the feasibility of zeta potential in adsorption characterization, zeta poten-
tial  of nanoparticles was measured as a function of peptide concentration and




pH. Relative changes of zeta potential on different pH buffers are shown in Fig-
ure 19.
Figure 19. Change of zeta potential as a function of peptide GLP-1 concentration. Positive
APSTCPSi nanoparticles are on the left and negative TCPSi nanoparticles on the right.
Concentration of nanoparticles was 50 µg/ml. pH varies from 3.0 (green) to 8.0 (red).
These results show that zeta potential is very sensitive to peptide adsorp-
tion and highlights the sensitivity of ELS measurements in the adsorption studies.
The  change of  zeta  potential  during the  adsorption is  a  product  of  the  charge
density of one peptide and the number of adsorbed peptides on the surface. This
can be seen in Figure 19. The change of zeta potential is largest when the peptide
and particle are oppositely charged. For APSTCPSi, this is at pH 8.0, when the
peptide  is  negatively  charged and particle  is  neutral  and for  TCPSi  at  pH 3.0,
when peptide is positively charged and particle is neutral. The biggest change of
zeta  potential  takes  place  at  low concentrations,  which is  probably  due to  the
screening effect of the first peptide layer that is formed on the particle surface.
The effect of peptide loading on the zeta potential of the PSi nanoparticles
was  also  studied with  two oppositely  charged peptides,  PYY and GLP-1.  The
peptide to particle mass ratio was 1:1.  The effect of peptide adsorption on the
zeta potential of PSi nanoparticles with different surface chemistries is presented
in Table V. The shift was largest for the THCPSi nanoparticles. The original zeta
potential in the corresponding pH was slightly negative (-15 mV), increased up
to  +40  mV when PYY was  added,  and decreased to  -44  mV when GLP-1  was
added.
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THCPSi - 15 ± 6 40 - 44
UnTHCPSi - 54 ± 4 13 - 53
TCPSi - 46 ± 3 4.4 - 53
APSTCPSi > 57 59 6.1
a Zeta potential of nanosuspension in corresponding pH condi-
tions estimated from the pH titrations (Figure 16).
In order to design good, agglomeration resistant suspensions, the selection
of  the  isotonic  medium  for  each  peptide-loaded  nanoparticle  could  be  made
based on the previously obtained information about the effect of each isotonic
media on the nanoparticles. The concept is illustrated in Figure 20. The change
of zeta potential is drastic when the payload is added to the THCPSi nanoparti-
cles. The addition of isotonic solution to the formulation can be done so that the
sufficiently high (for a stable suspension) zeta potential is maintained.
Figure 20. Example of the effect of loaded peptides to nanoparticles zeta potential and
selection of the isotonic medium.
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7.4 Studies on the interactions during the peptide loading (and re-
lease) (Papers III, IV)
In Paper III, PSi nanoparticles were used for the first time in peptide delivery in
vivo. Subcutaneously injected (sc) PSi nanoparticles sustained the release of the
peptide PYY over the 4 day measurement time (Figure 21a). The reference sc in-
jected peptide solution was eliminated from circulation after 12 hours. In other
words, nanoparticles were able to prolong the half-life of PYY from 26 min to
more than 20 hours. More hydrophobic surface chemistries, especially Un-
THCPSi, sustained the release longer than hydrophilic TOPSi, but the difference
was not large. All the sc PSi nanoparticles increased the relative bioavailability
and showed over 80 % absolute bioavailability.
The importance of the administration route was significant, which was
noted when similar nanoparticles with PYY loading were delivered intrave-
nously (Figure 21b). This time, the half-life increased marginally from 12 min to
20 min, 26 min, and 46 min for THCPSi, TOPSi, and UnTHCPSi nanoparticles,
respectively. Here, the differences between surface chemistries were even
smaller than with sc injection and the order different. THCPSi nanoparticles re-
leased the cargo fastest and showed lowest absolute bioavilability when com-
pared to PYY solution. The faster iv release was attributed to competitive protein
adsorption on systemic circulation.
(a) (b)
Figure 21. PYY plasma concentrations in mice after sc delivery (a) and  iv delivery (b)  in
THCPSi (□), TOPSi (∆) and UnTHCPSi (∗) nanoparticle formulations compared to PYY
solution. In sc delivery n = 5-6 for each nanoparticle and n= 4 for solution. In iv delivery
n = 6-10.  Results are calculated mean ± standard error of the mean.
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Peptide loading efficiency was also studied and results can be seen in Fig-
ure 22. The loading seems to take place quite fast, and after 30 min, the plateau
is  reached.  The  peptide  affinity  seems  to  be  higher  toward  hydrophobic  Un-
THCPSi and THCPSi surfaces than toward hydrophilic TOPSi surface. The pep-
tide to nanoparticle ratio was 2:5 ( = 0.4⁄ ) in this study. Another in
vitro test, where the ratio was adjusted to 2:25 (0.08), was made and loading effi-
ciency of >99.5 % for hydrophobic and >96 % for hydrophilic nanoparticles was
observed. For the in vivo studies, the PYY:PSi ratio was adjusted to 2:125 (0.016)
in sc administration and 2:1250 in iv administration. Though it should be safe to
say that, in these cases, the loading efficiency was close to 100 %.
Figure 22. Loading efficiency (mean ± standard deviation, n=4) of PYY to PSi nanoparti-
cles as a function of time. Peptide concentration was 1 mg/ml and PSi concentration 2.5
mg/ml. Remaining peptide amount in loading solution was measured with HPLC.
In vivo peptide release differences between surface chemistries and signif-
icantly different release rates between administration routes, together with the
observed strong affinity of GLP-1 and PYY toward the PSi surfaces in Paper I,
raised the question of the interactions between peptides and nanoparticles and
optimal loading conditions. Thus in Paper IV, adsorption and loading of peptide
GLP-1 was studied as a function of pH and concentration. The low concentration
was used in order to understand the interaction between surfaces and peptides
(Figure 23). At the lowest concentration, there is no clear difference in adsorption
at  different  pH  conditions  (except  at  pH  3.0)  for  APSTCPSi  particles,  but  for
TCPSi nanoparticles, the difference is clear. Since both surface chemistries show
a pH dependent charging behavior, the differences should also be seen in AP-
STCPSi, if the driving interaction would be electrostatic. The observation that
APSTCPSi  is  more  hydrophobic  (Table  IV)  could explain  the  pH independent
adsorption behavior. Either the driving force of GLP-1 adsorption on APSTCPSi
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is the hydrophobic interaction or the adsorption is driven by the changes on the
peptide structure, which may also be increased by the adsorbent’s hydrophobic
nature [230]. Results also show that the adsorption efficiency is almost 100 % for
APSTCPSi nanoparticles when the peptide to nanoparticle ratio is 1:5 (0.2) or
lower, as presented in Figure 23. The situation is also the same for TCPSi particles
with the smallest concentration when the ratio is 1:20 (0.05). This is in line with
the adsorption efficiency studies on Paper III, where near 100 % adsorption effi-
ciency was observed with the ratio 2:25 (0.08).
Nanoparticle loading with the maximum peptide concentration is shown
as a function of pH in Figure 23c. The impact of pH to the loading process is clear.
The strongest loading takes place at pH 5.0 for positively charged APSTCPSi na-
noparticles and from pH 4.0 to 5.0 for negatively charged TCPSi nanoparticles.
The pI of GLP-1 is at pH 4.6 so the results confirm the hypothesis and previous
findings  with  mesoporous  silica  observing  the  strongest  loading  near  the  pI
value of the loaded component [228].
At pH 4.0, negatively charged TCPSi nanoparticles adsorbed positively
charged peptide about 27 % more than positively charged particles, which may
be due to the electrostatic interaction between the peptide and the particle sur-
face.  A more  pronounced effect  of  opposite  charges  can be  seen in  pH values
below and above GLP-1’s pI. At pH 3, the peptide’s and APSTCPSi nanoparticles’
charges are highly positive while the charge of TCPSi is negative or neutral. At
this pH, loading to the TCPSi is moderate, while there is no loading at all in the
APSTCPSi nanoparticles. Similar effect can be seen on the other side of the pep-
tide’s  pI  where  neutral  or  weakly  positive  APSTCPSi  is  a  better  adsorbent  for
negatively charged peptide. Loading was 30 %, 75 % and 102 %, better on AP-
STCPSi compared on TCPSi at pH values 6.0, 7.0, and 8.0, respectively.
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Figure 23. Adsorbed peptide amount on PSi nanoparticles. The experiment was made as
a function of initial peptide concentration with two different particles (a) APSTCPSi and
(b) TCPSi and six different buffer pHs 3.0 (□), 4.0 (○), 5.0 (Δ), 6.0 (◊), 7.0 (+) and 8.0 (x).
Lines are fitted using the general Langmuir-Freundlich equation. The last of the graphs
above is plotted in order to better compare the differences (c). The concentration of par-
ticles and peptides was the same 1 mg/ml. The level of significance between the TCPSi
and APSTCPSi was set at probabilities of *p < 0.1, **p < 0.05 and ***p < 0.01.
In order to evaluate the amount of adsorbed peptides the following simple
calculation can be  made.  As  GLP mostly  consist  of  a  long α-helix  its  shape is
elongated [250] and is here approximated as an elliptic cylinder.  The length of
the cylinder is 4.9 nm and ellipsis axes are 1.1 nm and 1.5 nm. Thus if the longer
side of peptide adsorbs on the surface,  the minimum area it  covers is 5.4 nm2.
This information, together with the molecular mass and SSABET of PSi nanoparti-
cles, can be used for the calculation of theoretical adsorbed amount. In the case
of  monolayer,  the  adsorbed  amount  would  be  240  µg/mg  for  APSTCPSi  and
190 µg/mg for TCPSi. As can be seen in Figure 23c, loaded peptide amount near
the pI is more than double compared to theoretical calculation. The adsorption
of lysozyme ( ≈ 15	kDa), papain (23	kDa) and HAS (65	kDa) has before found
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to form less than a monolayer which was attributed to the big size of the proteins
and thus significantly smaller accessible surface area compared to nitrogen sorp-
tion methods [99]. GLP-1 is smaller molecule ( ≈ 3.4	kDa) than these previous
mentioned. This means that the first adsorbed layer on surface is thinner and the
surface characteristics may still affect the adsorption. This could explain the for-
mation of multilayer which is in line with previous results with mesoporous sil-
ica [228].
In summary, the adsorption at low concentrations seems to be driven by
different interactions than at high concentrations. We attributed this difference
to strong hydrophobic interactions between surface and peptide at low concen-
trations, which enables the high, 100 % loading efficiency. When peptide concen-
tration is increased to near the concentration of particles, the peptide-peptide in-
teraction dominates the loading and the neutral charge of the peptide enables the
high packing density and thus, higher loading degrees.
The different adsorption behavior at small concentrations gave us a reason
to study differences in desorption also. TCPSi nanoparticles were loaded in a 1:1
peptide solution at different pHs. Centrifuged nanoparticles were dispersed into
a pH 7.0 buffer solution, and the amount of peptide released after two hours was
measured with a UV-Vis spectrophotometer. The release dynamics were also
tested, and the maximum release was achieved after 90 minutes. Results showed
that the amount of released peptide is less than the loaded amount,  indicating
that there is a portion of irreversibly adsorbed peptides still attached to the na-
noparticles. The amount of released peptide was taken into account and the ad-
sorption behavior of GLP-1 to TCPSi nanoparticles is shown in Figure 24a with
the irreversible layer highlighted. In order to verify the irreversible adsorption,
we made a new desorption experiment with two cycles (Figure 24b). First in pH
7.0 and second in the same buffer with or without ethanol spiking. 20 vol-% eth-
anol on the solution increased the amount of released peptide and suppressed
the irreversible amount to half, which implicates that a significant amount of ap-
parently irreversibly adsorbed peptide was not covalently bonded on the surface.
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(a) (b)
Figure 24. Irreversibly (dashed) and reversibly adsorbed payload on TCPSi nanoparti-
cles in fist test with single release medium (a) and with second test with second desorp-
tion round in two different media (b).
The payload is typically reported as a loading degree. If the optimal pH 4.0
is used, the loading degree of the formulation is 32 %. If the irreversibly loaded
peptides are subtracted from the payload, the loading degree is 26 %, which is
still very good for biological drugs. Although irreversible adsorption is not re-
ported in the context of mesoporous nanoparticles before Paper IV, it is not an
uncommon observation when peptide adsorption on flat surfaces is studied. For
example, Pinholt et al. observed irreversible adsorption in the case of another
proglucagon originating peptide, GLP-2 [222].
7.5 Size, porosity and agglomeration: characterization challenges
of DLS (Paper V)
Characterization of nanoparticle size is crucial for applications and toxicity stud-
ies, but not a straightforward task. In order to tackle this problem, the thorough
light scattering study for mesoporous nanoparticles was made.
Two different silicon based materials, PSi and mesoporous silica, were
used. The size of nanoparticles was measured first with TEM, and a clear differ-
ence on particle shape between silica and PSi nanoparticles can be observed (Fig-
ure 25). The morphology of PSi nanoparticles is irregular. The particle size dis-
tribution was found to be similar in all studied particle batches, and the data fits
reasonably well to a log-normal distribution.
In  the  case  of  silica  nanoparticles,  the  TEM pictures  showed a  spherical
shape of particles, differences in pore structure, and the clear size difference. Log-
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normal  distributions  fit  well  to  the  data.  Sample  R-MSN shows the  narrowest
particle size distribution and sample H-MSN the widest. Porosity and pore ori-
entation of silica nanoparticles was confirmed. On P-MSN, pores are aligned par-
allel to each other while in R-MSN pores are radial, pointing towards the center
of the particle. H-MSN has a hollow core and radial porous structure in the shell.
S-SN and L-SN were  small  and large  non-porous  nanoparticles  used as  refer-
ences in the study.
c)
d)
Figure 25. Particle size distribution of studied silica nanoparticles (a) and PSi na-
noparticles (b). The example pictures of TEM results on respective order (c,d). Red
scale bar represents 20 nm (S-SN, L-SN and R-MSN), 50 nm (P-MSN) and 200 nm
(H-MSN).
In order to measure the radius of gyration , the Debye-Bueche fit was
used for the SLS result analysis of PSi nanoparticles (Figure 26a) as well  as P-
MSN, L-SN and S-SN samples. The scattering of R-MSN and H-MSN more re-
sembled a scattering of spherical nanoparticles, enabling the use of a Guinier plot
(Figure 26d). In the case of H-MSN, a Guinier plot was done to –values below
5 ⋅ 10 	 .  Scattering behavior above this value resembles the scattering of
non-porous hollow silica nanoparticles and is typical for core-shell particles [251],
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but does not fit to the Guinier model. Hydrodynamic sizes ( ) of studied nano-
particles were obtained with multiangle DLS measurements (Figure 26a,b). The
values of  and  are tabulated in Table VI.
Figure 26. Measured DLS results and fits for PSi (a) and silica (b) nanoparticles. Example
of SLS results and fits for the determination of  with Debye-Bueche (c) and Guinier (d)
models.
The decrease of  as a function of scattering angle (and scattering vector)
was observed for all PSi samples as well as L-SN, S-SN, and P-MSN samples.
That was attributed to a well-known phenomenon relating to the polydispersity
of the suspension under investigation and particle size itself [156]. The polydis-
persity  effect  arises  from the  fact  that  large  particles  ( > /20) are scattering
more  light  on  low  rather  than  high  angles,  which  means  that  in  polydisperse
samples,  the  effect  of  big  particles  is  more  important  on low angles.  The  only
limitation for this is if the hydrodynamic size of all the particles are below the
limit ( /20), which is not the case with these nanoparticles. Thus polydispersity
has an effect to the angular dependence of .  This observation was used in
order to quantify and compare the polydispersities between the samples.
All measured radiuses are tabulated on Table VI with the structural pa-
rameter ( / )  and  overestimations  between  the  hydrodynamic  radius  and
80 Results
TEM primary particle radius ( / ). This overestimation was significant for al-
most all samples. In the case of silica nanoparticles, the variation of the error be-
tween particle types was considerable as the smallest error (13 % overestimation)
was measured for the H-MSN sample and highest (148 %) for the S-SN sample.
For the PSi nanoparticles, the variation was smaller, ranging from 31 % to 65 %.




SSABET Re GSD Rh Rg Rh/Re Rg/Rh
m2/g nm nm nm
pPSi_190 190 72.1 0.36 94.1 80.2 1.31 0.85
nPSi_390 390 55.3 0.35 91.2 93.5 1.65 1.03
nPSi_350 350 57.5 0.30 84.4 81.8 1.47 0.97
nPSi_310 310 86.6 81.3 0.94
nPSi_480 480 69.3 0.29 97.1 98.8 1.40 1.02
P-MSN parallel pores 33.6 0.19 75.9 78.6 2.26 1.04
S-SN solid 24.6 0.17 61.0 68.0 2.48 1.11
L-SN solid 52.1 0.16 78.5 74.1 1.51 0.94
R-MSN radial pores 81.8 0.11 93.9 73.0 1.15 0.78
H-MSN hollow 190.7 0.22 215.1 179.5 1.13 0.83
When comparisons between the DLS and TEM radiuses are made, it must
be noted that these techniques and particle size distributions are fundamentally
different.  The  TEM  size  distribution  is  based  on  the  number  of  the  particles,
whereas the DLS distribution is based on the intensity of scattered light, which
weights the distribution towards larger sizes. Some error is therefore expected.
For a polydisperse sample, this error may be significant, so first we need to study
the polydispersity.
In the studied samples, the polydispersity may arise in two different ways:
from the initial  particle size distribution or agglomeration in the presence of a
medium. The intrinsic polydispersity can be quantified with a geometric stand-
ard deviation (GSD) of the size distribution from TEM studies. The agglomera-
tion caused polydispersity should be seen in the slope of  as explained before.
In the case of PSi nanoparticles, which all have a wide size distribution, no cor-
relation to either of these were found. For silica particles, there is a weak correla-
tion on  and error, which is a first hint of the agglomeration.
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The easiest way to analyze the morphology of the nanoparticles is to com-
pare the ratio of radius of gyration and hydrodynamic radius, / . Investiga-
tion of this value, with respect to the size error, reveals interesting behavior of
silica nanoparticles and the correlation is clear (Figure 27a). The bigger the error
is, the larger is / ,  also.  Noteworthy is  also  the  result  that / 	 does not
correlate with the porosity of silica nanoparticles. This confirms the agglomera-
tion of silica nanoparticles [252,253]. This is a significant observation, since the
common assumption is that the hydrodynamic radius and polydispersity index,
obtained from the one angle DLS measurement with CUMULANTS-analysis
could reveal if agglomerates are present. This is the deduction that we have also
made during the preparation of nanoparticle samples.
Figure 27. Correlation of structure parameter / 	compared to overestimation in the
hydrodynamic diameter for silica nanoparticles (a) and to SSABET with PSi nanoparticles
(b).
Differences between the TEM radius and hydrodynamic radius were less
pronounced in the case of PSi nanoparticles, but still clear. A clear difference to
silica nanoparticles was that the standard deviation correlates with the DLS slope,
which emphasizes the polydispersity of primary particles, not agglomerates. Un-
expectedly, a strong correlation between / 	 and specific surface area, SSABET
(Figure 27b) was found in PSi nanoparticles. The difference could arise from the
distribution and size of scattering centers in the PSi matrix as similarly observed
with silica aggregates [253]. This was a very interesting result and needs further
studies because it could give a way to characterize porosity of PSi nanoparticles
in solution. Unfortunately, an explanation for the error between DLS and TEM
was not found because of conflicting or weak correlations. Both of the LS radiuses,
 and , seem to overestimate the nanoparticles radiuses when compared to
the TEM radius, but by comparing these together, the correlation between / 	
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and SSA  shows that LS studies can be used in order to make more rigorous
particle size analysis.
8 Conclusions
One of the aims of this thesis was to study the zeta potential of PSi nanoparticles
in isotonic formulations and characterize the impact of peptide payload to zeta
potential. Zeta potential measurements, and especially IEP measurements, were
made and reported for the first time for PSi nanoparticles with different surface
chemistries. These measurements were found useful for surface chemistry char-
acterization studies. The IEP results indicate the preservation of the special char-
acteristics of the surface chemistries during the complex fabrication process of
PSi nanoparticles. The results also indicate successful surface functionalization,
highlighting the importance of the surface chemistry when controlling the zeta
potential of PSi nanoparticles in the biologically relevant pH area. In addition,
zeta potential was found to be useful for in situ degradation studies of surface
coating.
When it is desired to maintain the PSi nanosuspensions’ biocompatibility ,
one of the concerns is the stability of the suspension. It must be kept in mind that
zeta potential is not an intrinsic property of nanoparticles, but as we have demon-
strated, it is also affected by the other formulation components, like an isotonic
medium  and  the  loaded  peptides.  This  effect  is  significant,  and  the  impact  of
these components to the stability is critical. The studied peptides, GLP-1 and PYY,
had opposite effects to zeta potential of PSi nanoparticles. Especially for the neu-
tral and hydrophobic THCPSi nanoparticles, zeta potential was completely de-
termined by the adsorbed peptide. The selection of isotonic medium also plays a
role and they can be used in order to adjust zeta potential to the desired direction.
Concentrated electrolytes, such as isotonic salt solutions, caused a drastic drop
of zeta potential,  and those media cannot be recommended to electrostatically
stabilized nanoparticles. Low molecular weight PEG and HEPES provided suffi-
cient zeta potential for a stable formulation of all studied nanoparticles.
One of the general aims was to find out the suitability of PSi nanoparticles
for sc and iv peptide delivery, and by altering the surface chemistry, understand
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the effect of surface chemistry on peptide release rate and bioavailability. PSi na-
noparticles were found to be suitable for PYY delivery in sc administration in
vivo. In sc delivery, PSi improved the delivery showing sustained release with
high absolute bioavailability. The surface chemistry affected the delivery, and
hydrophobic carriers showed more prolonged release. When nanoparticles were
administered intravenously, nanoparticles’ effect to sustain the release was al-
most nonexistent.  This was attributed to competitive adsorption of blood pro-
teins and rapid clearance from the circulation.
Interactions driving adsorption and loading of peptide (GLP-1) to PSi na-
noparticles was studied in order to find optimal peptide loading conditions, and
to find explanations for behavior of PSi nanoparticles in vivo studies. At low con-
centrations, both hydrophobic and electrostatic interactions were observed de-
pending on the surface chemistry. The electrostatic effect seemed to be present
in the adsorption at higher concentration, but the highest loading degrees were
obtained when the peptide charge was near zero. Thus, we have concluded that
the electrostatic attraction between the peptide and the surface is overempha-
sized when the objective is to maximize the loading degree. We also noted that
strong interaction between the peptide and the nanoparticle could lead to irre-
versible adsorption. This highlights the importance of peptide-peptide interac-
tion in the pores because the peptides that are firstly adsorbed on porous silicon
may form a protective layer and facilitate the easy desorption. When the condi-
tions are selected carefully, large amount of easily desorbing peptides can still be
loaded into porous silicon nanoparticles. With the optimal loading pH, the load-
ing degree was 32 %, and after subtracting the irreversibly loaded layer, the load-
ing degree was still 26 %.
When adsorption and loading studies are reflected with the in vivo studies,
some contemplations can be made. It is possible that the low peptide concentra-
tions in loading solutions that were used in in vivo studies, had caused the strong
interaction between particle surface and peptide. This would have been espe-
cially likely with hydrophobic surfaces. Since in in vivo studies hydrophobic na-
noparticles are releasing peptides at the slowest rate, the strong interaction could
be the explaining factor. Particle dissolution might also play a role in this behav-
ior  since  TOPSi  degrades  faster  than  THCPSi  or  UnTHCPSi.  The  irreversible
layer, which was observed in loading experiments, may only desorb when parti-
cles are dissolving.
In the fifth paper, we wanted to show how conventional light scattering
methods can be used for a rigorous characterization of medium sensitive nano-
particles properties, like size, stability, and porosity. The size of silicon based
mesoporous nanoparticles were measured with three different techniques, TEM,
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DLS, and SLS. The primary particle radius, , was measured with TEM, hydro-
dynamic radius, , with DLS, and radius of gyration, , with SLS. Recently
DLS has become the most common method to characterize nanoparticle size and
big differences between DLS and TEM sizes have been observed. These differ-
ences are normally attributed to the fundamental difference between intensity
and number weighted particle size distributions and the differences between dry
and hydrodynamic radii of particles. We studied the sizes of PSi nanoparticles
and MSN and, as expected, we also observed remarkable differences between the
hydrodynamic  radius  and primary particle  radius.  The  overestimation of  DLS
varied from 13 % to 148 %.
The overestimation, in the case of the silica nanoparticles, was attributed
to agglomeration of primary particles. This was the case despite the careful se-
lection of the dispersion medium and monitoring the size with one angle DLS. If
the porosity plays a role on the measurement, we were not able to distinguish it
because of the strong agglomeration effect. The overestimation affected the struc-
ture parameter, / ,  so  that  the  overestimation between DLS and TEM also
led to the high structure parameter. This was attributed to the fractal nature of
the agglomerates. In the case of PSi nanoparticles, the clear correlation between
/  and  the  specific  surface  area  was  observed,  which  could  be  due  to  the
shape of the primary particle and the distribution of scattering centers inside one
nanoparticle. This behavior needs more studies, and in the future, might open
new ways to characterize the porosity of PSi nanoparticles.
Overall, the results of this thesis highlight the importance to characterize
nanoparticles in their native colloidal state. Even more important is to test and
apply these characterization methods to biorelevant media. With this purpose,
light scattering, and especially multiangle light scattering, instruments have
shown their versatility and analytical power.
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